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Abstract 
 
Background 
As populations age, societies are becoming challenged with age-related diseases such as 
dementia. There is a need to identify determinants of cognitive disabilities, so that policy 
and preventative programs can be further developed. A previous review has highlighted an 
association between loneliness and cognitive function (Boss, Kang & Branson, 2015). 
However, this review did not formally consider the quality of studies included in relation 
to study outcomes and only included research from January 2000-July 2013, limiting the 
strength of interpretations. 
 
Objective 
The aim of this review was to examine, considering study quality, whether there is 
evidence for an association between loneliness and cognitive function. 
  
Method 
Primary quantitative research assessing the relationship between loneliness and cognitive 
function among older adults was systematically searched across six databases on 31st 
January 2018. Data were extracted, synthesised and summarised: describing the 
characteristics of research participants, assessment tools, and results. The AXIS 
methodological quality rating tool was used to assess the quality and risk of biases of 
studies.  
 
Results 
Fifteen studies were identified. Quality and risk of bias among studies varied. Many did 
not use a robust psychometric measure to measure loneliness. Despite variation in study 
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design, most studies reported similar findings of a significant and negative association 
between loneliness and cognitive function. 
 
Conclusions 
Increased loneliness is associated with reduced cognitive function. Loneliness may 
therefore be an indicator of those at increased risk of cognitive decline. More longitudinal 
research is required to explore the causal relationship association between loneliness and 
cognitive function. 
 
Key words: older adults, dementia, loneliness, cognitive function 
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Introduction 
 
As populations age, societies are becoming challenged with age-related diseases such as 
dementia. Currently, there are around 50 million people with dementia worldwide, and this 
is projected to increase to 82 million by 2030 (WHO, 2017). As such, there is a need to 
identify determinants of cognitive disabilities, so that policy and preventative programs 
can be further developed. Biological, psychological and social factors are all recognised to 
be important determinants of health, wellbeing and the development of age-related 
conditions. One such psychosocial factor is loneliness. Loneliness has been defined as “a 
distressing feeling that accompanies the perception that one’s social needs are not being 
met by the quantity, or especially the quality of one’s social relationships” (Hawkley & 
Cacioppo, 2010, pp.218). Loneliness is therefore a multifaceted concept reflecting one’s 
subjective experience of relationships and social network.  
 
It has been argued that individuals who are lonely have increased risk of developing 
dementia (Holwerda, Deeg, Beekman et al., 2014), including Alzheimer’s disease (Wilson, 
Krueger, Schneider et al., 2007) and generally experience more rapid cognitive decline 
than individuals who are not lonely (Conroy, Golden, Jeffares et al., 2010). Several 
mechanisms have been proposed for the effect of loneliness upon cognition, potentially 
leading to dementia. It has been hypothesised that loneliness may affect pathways of 
cognitive and memory domains by reducing cognitive stimulation (Wilson et al., 2007). In 
one study, boredom-proneness (an inability to engage and maintain attention on any 
object) was linked with loneliness (Conroy et al., 2010). Loneliness may therefore share a 
common underlying executive cognitive process with impaired effortful attention, whether 
on social relationships in the case of loneliness or other objects or activities in the case of 
boredom-proneness (Conroy et al., 2010). Longitudinal research has also implicated a 
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bidirectional loneliness-cognition relationship over time (Zhong, Chen, Tu et al., 2017). 
Less engagement in social activities and reduced social network size due to diminished 
cognition are alternative explanations proposed for this reverse relationship (Zhong et al., 
2017). However, these explanations are tentative and further research is required to explain 
the association between loneliness and cognitive function.  
The literature on loneliness and cognition was reviewed by Boss, Kang & Branson (2015), 
who concluded that greater loneliness is associated with lower cognitive function, though 
some initial correlations were not significant after controlling for a range of demographic 
and psychosocial risk factors thought to influence loneliness. However, this review did not 
formally consider the quality of studies included in relation to study outcomes, and only 
research from January 2000-July 2013 was reviewed, limiting the conclusions that can be 
drawn from this.  
Looking at indicators of the relationship between loneliness and cognitive function in older 
people prior to the development of a cognitive age-related condition is important as this 
period potentially provides the best opportunity for psychosocial intervention.  
 
Aims and Objectives 
 
 
The aim of this review was to examine, taking into account study quality, whether there is 
evidence for an association between loneliness and cognitive function.  
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Methods 
 
Studies selected for this systematic review included primary quantitative research 
assessing the relationship between loneliness and cognitive functioning among older adults 
(without an existing diagnosed cognitive age-related condition).  
 
 
Search Strategy 
 
 
A search of EMBASE, Medline, Psychinfo, Ebsco, Cochrane, and CINAHL databases was 
conducted on 31st January 2018. Subject headings were searched for Loneliness, Social 
Isolation, Cognition, Memory, Aged and Ageing. Search terms (shown below) were 
applied to the title, abstract and key words using the Boolean operators “AND” and “OR”. 
Truncation, indicated by the asterisk, was used to ensure any word endings following the 
truncation would be identified.   
 
Lonel* OR  Isolation 
AND 
Cogniti* OR Memory 
AND 
Aged OR Ageing OR Geriatric* OR Older Adult* OR Older People OR Older Person OR 
Elderly 
 
No limits were placed on dates. Titles and abstracts were screened against eligibility 
criteria. This process was repeated by assessing the full article of the remaining selection 
of records. The reference lists of included articles were then reviewed. Only peer reviewed 
published articles that met criteria were included. Data extraction (i.e. of study population, 
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outcome measure type for loneliness and cognition, results) was completed for final 
eligible articles. Evaluation using the AXIS methodological quality rating tool (Downes, 
Brennan, Williams et al., 2016) was also conducted on the final articles. 
 
Inclusion and Exclusion Criteria 
 
Studies were included if: 
• They were primary quantitative research  
• They assessed the association between loneliness and cognitive function among 
older adults 
 
Studies were excluded if 
• They were not written in English 
• They did not focus on loneliness or include a measure of loneliness 
• They included participants with a diagnosed cognitive age related condition at 
baseline 
• They included participants who were under the age of 65 years old.  
 
Search Outcome 
 
Figure 1 provides an overview of the outcome of searches and screening process followed 
within this review. A total of 3129 studies were identified from database searches 
excluding duplicates, and 15 studies were eligible for inclusion.  
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Figure 1. Flow Diagram of Selection of Papers for Inclusion in the Systematic Review 
 
 
Quality Appraisal 
 
The AXIS (Downes et al., 2016) was developed to assess the quality and risk of bias in 
observational cross-sectional studies. It comprises 20 questions, relating to quality of 
reporting, study design, and the possible introduction of biases. All questions can also be 
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applied to longitudinal study designs. As such, this tool was used to assess all eligible 
articles. To evaluate inter-rater reliability, a sample (60%) of the included articles was 
independently rated by a second rater. There was 85-100% agreement between raters 
across papers by assigning ‘yes’, ‘no’ or ‘do not know/comment’ across all 20 
components. Following discussion, 100% agreement was reached.  
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Results 
 
Study Characteristics 
 
15 journal articles met inclusion criteria. Table 1 summarises the characteristics of 
included studies. Seven were cross sectional and eight were longitudinal with follow-up 
periods ranging from one year to 68 years. Two studies (Gow, Corley, Starr et al., 2013; 
Gow, Pattie, Whiteman et al., 2007) used the same cohort of participants, The Lothian 
Birth Cohort, 1921, although analysis of the data differed with different research questions. 
Nine studies were conducted in Europe, and the remaining studies in Canada, USA, and 
China. Number of participants per study ranged from 189 to 14,199, with a total of 45,914 
participants across all studies. All authors provided a description of sampling methods and 
sample size, although specific details varied among studies. Thirteen studies included male 
and female samples, and two studies included male only samples (Tijhuis et al., 1999; 
Tzang, Yang, Yeh et al., 2015). Samples were mostly community dwelling and 
independently living older adults. One study included a small number of participants in 
nursing homes, accounting for 4% of the total sample (Wilson et al., 2007). Another study 
included participants recruited from a veteran’s home (Tzang, et al., 2015). The health 
status varied among participants, however, all were free from a dementia diagnosis at 
baseline.  
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Table 1: Characteristics of Included studies 
 
Cross sectional Studies 
Author and Year Aims Characteristics of sample and setting Results 
Conroy et al. (2010) To examine the relationship of 
cognitive impairment, with 
loneliness, boredom-
proneness, social relations, 
and depression.  
 
N = 802 (423, 53% women) 
Age = 65-102 (M= 74.2 years) 
 
Participants were part of a population survey 
of persons aged 65> living in the Irish 
Republic 
 
Community dwelling 
  
Irish population 
Loneliness is associated with reduced cognitive function 
in older age (p=0.003), and clusters with other factors 
associated with cognitive reserve (p=0.001) 
 
 
Gilmour (2011) To examine correlates of low 
performance on four cognitive 
tasks among older adults 
without Alzheimer disease or 
dementia 
 
 
N=13,176 
Males and females 
Age > 65 years 
 
Community dwelling 
 
Canada  
Loneliness was negatively correlated with worse 
performance in immediate recall, executive function, 
semantic fluency, and processing speed (all p<0.01) 
 
Gow et al. (2013) To examine associations of 
diverse measures of social 
contact and support with 
cognitive ability 
 
N= 1091 males and females (M=70 years) 
Participants were part of the Lothian Birth 
Cohort, 1936 
 
Community dwelling 
 
Scotland 
Loneliness was negatively correlated with general 
cognitive ability (Spearman’s rho = -0.14, p<0.0001), 
processing speed (Spearman’s rho = -0.12, p<0.001) and 
memory (Spearman’s rho = -0.08, p<0.01) 
When all variables were examined in separate ANCOVAs, 
lower loneliness was significantly better correlated with 
better general cognitive abilities at age 70 (p<0.05) 
Holmen et al. (1992) To investigate experienced 
loneliness among the elderly 
N= 1725 males and females 
Age ³75 
Participants were part of the Kungsholmen 
project 
 
Community Dwelling 
 
Stockholm 
High frequency of loneliness was found among 
participants with reduced cognitive function. MMSE 
scores explained loneliness in a stepwise regression 
analysis (p<0.05).  
O’Luanaigh et al. (2012) To explore associations 
between loneliness and 
N= 466 males and females 
M age= 75.5 years 
Loneliness was negatively correlated with global cognitive 
function (p = 0.047), category fluency (p < 0.05), 
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cognition and to determine 
whether specific cognitive 
domains are associated with 
loneliness  
 
Participants were part of The Dublin Healthy 
Ageing Study 
Community dwelling 
 
Ireland 
psychomotor processing speed (p = 0.036), immediate 
visual memory (p = 0.003), visual memory (p = 0.003), 
pre-morbid IQ (p < 0.001), and visual memory savings (p 
= 0.003).  
Stessman et al. (1996) To find the determinants of 
feelings of loneliness in 70 
year olds living in Jerusalem. 
N= 605 (Mean age 69.95 ±0.3 years) 
 
Community Dwelling 
 
Jerusalem 
Impaired cognitive function was not found to be 
associated with loneliness 
Tzang et al. 2015 To investigate the effect of 
loneliness and depression on 
total as well as specific 
cognitive domains in 
cognitively normal male 
subjects 
 
N= 189 non-demented male participants  
Age 65-98 years (M=80.2)  
Veteran’s home  
Taiwan 
Depression and loneliness are negatively correlated with 
global cognitive function as evaluated with CASI (r=–
0.227, p=0.002; r=–0.214, p=0.003, respectively). The 
domains of Attention, Orientation, Abstraction and 
judgment, and List-generating fluency of cognitive 
function were specifically associated with loneliness. 
Longitudinal Studies 
Author and Year Aims and Follow-up periods Characteristics of sample and setting Results 
Donovan et al. (2016) To examine the reciprocal 
relations of loneliness and 
cognitive function in older 
adults, adjusting for social 
network, depression and other 
demographic and health 
related-factors 
12 year follow up 
 
N= 8382 Males and females  
Age ³65  
Non-Hispanic white and black Participants 
part of the US Health and Retirement Study 
from 1998 to 2010 
Community Dwelling 
 United States 
Baseline loneliness predicted accelerated cognitive decline 
over 12 years independent of baseline socio-demographic 
factors, social network, health conditions and depression 
(b=0.2, p=0.002). Reciprocally, poorer baseline cognition 
was associated with greater odds of loneliness over time in 
adjusted analysis (OR 1.3, 95% CI (1.1-1.5) p=0.005), but 
not when controlling for baseline depression. 
Gow et al. (2007) To examine associations 
between early cognitive ability 
and later social networks and 
social support, and to examine 
associations between social 
N= 497 males (42%) and females (M=79) 
years 
Participants were part of the Lothian Birth 
Cohort, 1936 
Loneliness was negatively correlated with significant 
negative change in cognition (r = −0.22, p = < 0.001)  
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networks, social support and 
cognitive change between age 
11 and 79 
 
68 year follow up 
Community Dwelling  
Scotland 
 
Gow & Mortensen 2016 To examine associations 
between social resources and 
cognitive ageing 
 30 year follow up, at 10 year 
intervals  
N=802 (436 men; 366 female) 
Age 50 – 80 years  
Participants were part of The Glostrup 
Cohort – longitudinal study of health and 
ageing.  
Community Dwelling 
Copenhagen 
When the social resources showing significant 
associations were considered together (accounting for sex, 
education and social class), loneliness at age 70 was 
associated with lower cognitive ability level and greater 
cognitive decline at age 80, while married individuals 
experienced less decline  
 
 
Holwerda et al. (2014) To examine associations 
between social isolation, 
feelings of loneliness, and 
incident dementia in a cohort 
of older people without 
dementia  
3-year follow-up 
N= 2173 males and females. Age = 65-86 
years 
Participants were part of the Amsterdam 
Study of the Elderly (AMSTEL) 
 
Community dwelling 
Netherlands 
The decrease in global cognitive function score from 
baseline to follow-up was more pronounced in those with 
greater loneliness (baseline: M = 27.52, SD = 2.12, follow-
up: M = 25.84, SD = 4.11) when compared to those with 
less loneliness (baseline: M = 28.05, SD = 1.84, follow-up: 
M = 27.06, SD = 2.71).  
Feeling lonely rather than being alone is associated with 
an increased risk of dementia (OR = 2.56, 95% CI = 1.82–
3.61).  
Tijhuis et al. 1999  To investigate (i) whether 
loneliness increased in old 
age, and if so, whether it 
relates to ageing itself, to time 
trends or to cohort effects and 
(ii) the relationship between 
changes in institutionalisation, 
partner status and health and 
loneliness 
5, 10 year follow up 
N= 939 males 
Age 65> 
 
Participants were part of the Zutphen Elderly 
Study  
 
Community Dwelling 
Netherlands  
Changes in cognitive function were not related to 
loneliness 
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Tilvis et al. (2004) To identify preventable and 
treatable risk factors of 
cognitive decline.  
1, 5, and 10-year follow-up 
 
N = 650 males and females, 
Age= 75 > 
Participants were obtained from The 
Helsinki Aging Study  
Community dwelling 
Finland 
At 10-year follow-up only, baseline loneliness scores were 
significantly correlated with a decline in MMSE scores 
(RR = 3.0, 95% CI = 1.4–6.8).  
 
 
Wilson et al. (2007) To test the hypothesis that 
loneliness is associated with 
increased risk of Alzheimer 
disease (AD).  
4 years of annual follow-up  
 
N = 823 males and females (M age = 81 
years)  
Participants were obtained from the Rush 
Memory and Aging project 
Community dwelling, nursing homes 
United States  
 
Greater loneliness at baseline was associated with the 
presence of dementia at follow up (p < 0.01).  
Participants with higher loneliness were 2.1 times more 
likely to develop AD compared to those with low 
loneliness (RR = 1.51, 95% CI = 1.063–2.14).  
Loneliness was negatively correlated with all cognitive 
domains at baseline, as well as with more rapid decline 
over time (all p < 0.01).  
 
Zhong et al. (2017) To examine the relationship 
between loneliness and 
cognitive function and to 
explore the mediating role of 
physical health on the 
loneliness–cognition 
relationship in Chinese older 
adults  
2, 4, 7, 10, 13 year follow up 
Data came from a nationally representative 
sample of 14,199 Chinese OAs (aged 65+) 
from 2002, 2005, 2008, and 2011 waves of 
the Chinese Longitudinal Healthy Longevity 
Survey  
Community Dwelling 
China 
Severe loneliness at prior assessment points was 
significantly associated with poorer cognitive function at 
subsequent assessments, and vice versa.  
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Measurements of Loneliness 
 
Most studies utilised one or two Likert-style or yes/no question(s) to measure loneliness. 
Two studies measured loneliness with the De-Jong Gierveld Scale for Loneliness (Tijhuis 
et al., 1999; Wilson et al., 2007), although one of these studies (Wilson et al., 2007) used a 
modified version of the scale. In one study, loneliness was measured with the Loneliness 
Scale (University of California, Los Angeles, UCLA version 3) (Tzang et al., 2015). 
Gilmour (2011) also appears to use this scale, although this is not explicitly stated but the 
description of how loneliness was measured fits the description for this tool. For further 
information regarding these tools, please refer to Appendix 1.3.  
 
Loneliness and Global Cognitive Function/General Cognitive Ability 
 
Eleven studies explored the association between loneliness and general or global cognition. 
Five were longitudinal studies follow up periods between one and 30 years (Donovan, 
Rentz, Sperling et al., 2016; Gow & Mortensen, 2016; Tilvis et al., 2004; Tijhuis et al., 
1999; Zhong et al., 2017). The majority of these studies found a significant association 
between these two variables.  
 
Tilvis et al. (2004) found that loneliness significantly predicts cognitive decline with a 10 
year follow-up period. Similarly, Gow & Mortensen (2016) found that loneliness at age 70 
was associated with greater cognitive decline at age 80 (-0.582, p=0.011). Contrary to this, 
Tijhuis et al. (1999) found no significant association between loneliness and cognition over 
10 years. Of note, a male only sample was utilised within this latter sample.  
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Two studies investigated the reciprocal relationship of loneliness and cognitive function 
and found similar results. Donovan et al. (2016) reported that loneliness at baseline 
predicted accelerated cognitive decline over 12 years independent of socio-demographic 
factors, social network, health conditions and depression (b = -0.2, p=0.002). Reciprocally, 
poorer cognition at baseline was associated with greater odds of loneliness over time in 
adjusted analysis (OR 1.3, 95% CI (1.1-1.5) p=0.005), but this association did not persist 
when controlling for baseline depression. Zhong et al (2017) found that more severe 
loneliness at prior assessment points was significantly associated with poorer cognitive 
function at subsequent assessments and vice versa (p<0.001); indicating loneliness has an 
adverse impact upon cognitive functioning, but also that cognitive dysfunction may 
exacerbate loneliness. This association persisted after controlling for a range of socio-
demographic, social network and health factors. Of note, they did not control for 
depression.    
 
Six cross-sectional studies explored the association between loneliness and global 
cognitive function and found mixed results. Five of these studies (Conroy et al., 2010; 
Holmen et al.,1992; Gow et al., 2013; O’Luanaigh et al., 2012; Tzang et al., 2015) found 
loneliness to be significantly and negatively associated with cognitive function. 
Additionally, O’Luanaigh et al. (2012) found this association persisted after controlling for 
depression and social networks. However, Gow et al. (2013) found this relationship did not 
persist when depression symptoms were considered.  
 
One cross-sectional study (Stessman, Ginsberg, Klein et al., 1999) found no association 
between cognitive status and loneliness. Of note, this study failed to report what cognitive 
assessment was utilised to measure cognitive function.  
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Loneliness and Dementia/Alzheimer’s Disease 
 
 
Two longitudinal studies explored the association between loneliness and incidence of 
dementia (Holwerda et al., 2012) and risk of Alzheimer’s disease (Wilson et al., 2007). 
Both studies found that baseline loneliness significantly increased the risk of dementia 
after a three year follow-up (Holwerda et al., 2012) and Alzheimer’s disease after a four 
year follow-up (Wilson et al., 2007). These associations persisted after controlling for 
social isolation (Wilson et al., 2007) and demographic, somatic and psychiatric risk factors 
(Holwerda et al., 2012).  
 
Loneliness and Memory 
 
Six studies explored the association between loneliness and various domains of memory, 
including immediate and delayed recall, visual and general memory, episodic, semantic 
and working memory (Donovan et al., 2016; Gilmour, 2011; Gow et al., 2013; O’Luanaigh 
et al., 2012; Tzang et al., 2015; Wilson et al., 2007).  Findings were mixed with only some 
studies reporting significant associations.  
 
Gilmour (2011) explored immediate and delayed recall and found significant and negative 
correlations of loneliness with immediate recall only (p<0.01). Whereas, O’Luanaigh et al. 
(2012) explored delayed recall only and found greater loneliness was associated with 
worse performance on delayed recall (p<0.05). In contrast to this, Tzang et al. (2015) 
assessed for short term, long term and working memory and found no significant 
associations with loneliness. 
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In their longitudinal study, Wilson et al. (2007) measured episodic, semantic and working 
memory, and reported significant and negative associations with loneliness at baseline, but 
only semantic memory remained significant at the fourth year follow-up period (p=0.01) 
when controlling for demographic factors.  
 
O’Luanaigh et al. (2012) found that loneliness was significantly associated with reduced 
visual memory. These associations persisted when controlling for a wide range of 
demographic and social network factors.  
 
Gow et al. (2013) explored general memory and found that loneliness was significantly 
and negatively associated with memory in bivariate correlations (p<0.01), however this 
association was no longer significant when considering demographic factors and childhood 
IQ.  
 
Loneliness and Executive Function/Attention  
 
Two studies explored loneliness and executive function/attention. These studies were 
similar in design, but varied considerably in sample size from 189 (Tzang et al., 2015) to 
13,176 participants (Gilmour, 2011). Tzang et al. (2015) found attention, orientation, 
abstraction and judgement were specifically associated with loneliness. In their larger 
study, Gilmour (2011) found a significant and negative association between loneliness and 
executive function (p<0.01). However, when social interaction (frequent participation in 
community events) was considered, the negative association between these two variables 
no longer continued.  
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Loneliness and Intelligence 
 
Two population based studies measured cognitive domains related to intelligence (Gow et 
al., 2007 & O’Luanaigh et al., 2012). Whilst these studies differed in design, they reported 
similar findings. Gow et al. (2007) assessed the association between early cognitive ability 
and loneliness later in life using the Lothian Birth Cohort, 1921 with a 68 year follow up. 
Cognitive function was assessed between the ages of 11 and 79 years, and loneliness was 
assessed at the age of 79 years only.  Results revealed that individuals reporting greater 
loneliness had poorer cognitive function at age of 79, and this association persisted after 
controlling for demographic factors and age-11 IQ (Gow et al., 2007). O’Luanaigh et al. 
(2012) used a cross-sectional approach with participants in The Dublin Healthy Ageing 
Study and measured loneliness with IQ. Results revealed that increased loneliness was 
significantly correlated with worse estimated pre-morbid IQ (p<0.05).  
 
Loneliness and Processing Speed 
 
Two cross-sectional studies found significant and negative associations between loneliness 
and processing speed (O’Luanaigh et al., 2012; Gow et al. 2013). Sample size ranged from 
466 (O’Luanaigh et al., 2012) to 1091 (Gow et al., 2013). Whilst O’Luanaigh et al (2012) 
found this significant association to persist after controlling for depression, pre-morbid IQ, 
global cognition and other demographic factors, Gow et al. (2013) found that the 
association between loneliness and processing speed was no longer significant after 
considering depression scores. As such, this research reflects conflicting findings with 
regard to the influence loneliness has upon mood.  
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Loneliness and Verbal Fluency 
 
O’Luanaigh et al. (2012) reported no significant associations between verbal fluency and 
loneliness when controlling for depression, social networks, and a range of demographic 
factors (O’Luanaigh et al., 2012). Whereas, Tzang et al. (2015) found that list-generating 
fluency was associated with loneliness (p=0.005).  
 
Critical Appraisal 
 
The design quality and risk of bias varied among studies. A breakdown of how studies 
were appraised using the AXIS, as well as details of covariates controlled for within 
studies, is presented in Appendix 1.2. No studies justified sample size. One study’s (Tzang 
et al., 2015) sample frame was not taken from an appropriate population that closely 
represented the target population being investigated, and another study (Zhong et al., 2017) 
had funding sources conflicts of interest that may have affected the authors’ interpretation 
of the results. Only three studies used a validated measure for assessing loneliness among 
participants (Tijhuis et al., 1999; Tzang et al., 2015; Wilson et al., 2007), which may have 
affected the validity of results among the other 12 studies.  Seven studies raised concerns 
about potential non-response bias (Conroy et al., 2010; Donovan et al., 2016; Gow et al., 
2013; Holmen et al., 1992; O’Luanaigh et al., 2012; Tilvis et al., 2004; Zhong et al., 2017), 
which may have affected validity of results. In terms of the quality of reporting among 
studies, five failed to discuss limitations (Conroy et al., 2010; Gilmour, 2011; Holmen et 
al., 1992; Stessman et al., 1996; Tijhuis et al., 1999), three did not adequately describe the 
methods (Gilmour, 2011; Holmen et al., 1992; Stessman et al., 1996), and six did not 
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adequately describe basic data (Gilmour, 2011; Gow & Mortensen, 2016; Gow et al., 2007; 
Holmen et al., 1992; O’Luanaigh et al., 2012; Stessman et al., 1996).  
 
Only two studies found no association between loneliness and cognitive function 
(Stessman et al., 1996; Tijhuis et al., 1999). Tijhuis et al. (1999) used a male only sample 
and did not adequately describe basic data, limiting conclusions that could be made. 
Stessman et al. (1999) did not use a validated psychometric measure to assess loneliness 
and also failed to state the tool used to measure cognitive function, indicating potential risk 
of bias. As such, these two studies were considered low quality. Of note, quality and risk 
of bias varied among studies that did find an association between loneliness and cognitive 
function, with some having low risk of bias (e.g.Wilson et al., 2007) and others having 
potential high risk (e.g. Conroy et al., 2010). Therefore, the quality and risk of bias among 
studies did not appear to affect the outcome of results.  
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Discussion 
 
This systematic review examined the evidence relating to the association between 
loneliness and cognitive function among older adults. Results largely indicate that 
increased loneliness is associated with lower cognitive function. This association was most 
significant when loneliness was explored in relation to global cognitive function, with a 
large number of studies providing evidence for this (Conroy et al., 2010; Donovan et al., 
2016; Gow & Mortensen, 2016; Gow et al., 2013; Holmen et al., 1992; O’Luanaigh et al., 
2012; Tilvis et al., 2004; Tzang et al., 2015; Zhong et al., 2017). Of these studies, some 
found this association to persist after controlling for demographic and psychosocial risk 
factors thought to influence loneliness (Donovan et al., 2016; Gow & Mortenson 2016; 
O’Luanaigh et al., 2012). This review also produced some evidence that there is a direct 
effect of cognition on loneliness, with two studies reporting that poorer cognition at 
baseline was associated with increased loneliness over time (Donovan et al., 2016; Zhong 
et al., 2017). However, this association did not persist when controlling for depression 
(Donovan et al., 2016). It could be that depression is a consequence of loneliness, making 
them highly correlated, contributing to this finding. Nevertheless, there was less evidence 
for the effect of cognition on loneliness.   
 
Whilst there was variation in the way in which loneliness was measured, results were 
largely consistent with many studies finding a negative association between loneliness and 
cognitive function. Of the two studies that found no association between loneliness and 
cognitive function, one used a validated tool to measure loneliness (Tijhuis et al., 1999), 
whereas the other study used one Likert scale style question to measure loneliness 
(Stessman et al., 1996).  
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Whilst an association was found for loneliness and cognitive function among studies that 
did not use a more extensive psychometric tool, there is still a risk that measuring 
loneliness in a more simplistic way (e.g. using one or two binary or Likert style questions) 
will not capture the multifaceted nature of this concept. The De-Jong Gierveld Scale for 
Loneliness was utilised in two studies (Tijhuis et al., 1999; Wilson et al., 2007) and 
includes both positive and negative questions about emotional loneliness (missing an 
intimate relationship) and social loneliness (missing a wider social network). This scale 
was designed for use with older adults. The UCLA Loneliness Scale was utilised in one 
study (Tzang et al., 2015). It was developed to assess subjective feelings of loneliness or 
social isolation. Questions are worded in a negative and positive direction. The third 
version of the scale was simplified to facilitate administration of the measure to less 
educated populations, such as older adults. A focus on different aspects of loneliness will 
better capture the multifaceted nature of this construct. As such, these measures may allow 
for a more comprehensive assessment of loneliness among older adults. 
 
When studies controlled for demographic and risk factors thought to influence loneliness, 
the relationship between greater loneliness and decreased cognitive function persisted for 
global cognitive function (Tilvis et al., 2004; Wilson et al., 2007; Zhong et al., 2017; 
Donovan et al., 2016; Tzang et al., 2015; Gow et al., 2007; Gow and Mortensen, 2016; 
Conroy et al., 2010), risk of dementia (Holwerda et al., 2014) semantic memory, 
processing speed (Gilmour, 2011) and visual memory (O’Luanaigh et al., 2012).  
 
In addition, when controlling for depression/depressive symptoms the association between 
greater loneliness and worse global cognitive function (Donovan et al., 2016; Tzang et al 
2015; O’Luanaigh et al., 2012) and dementia (Holwerda et al., 2014) persisted. Gow et al. 
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(2013) was the only study to find that the significant association between greater loneliness 
and reduced global cognitive ability no longer persisted after controlling for symptoms of 
depression, suggesting that symptoms of depression partly accounted for this association 
among participants. Gow et al. (2013) discuss that, given this, it is possible that loneliness 
is affecting pathways more proximal to cognitive function, such as depression. However, a 
number of studies within this review indicate that increased loneliness is associated with 
cognitive decline, independent of depression.   
 
Some studies found that the association between loneliness and cognitive functioning 
persisted after controlling for social network (Donovan et al., 2016; O’Luanaigh et al., 
2012; Zhong et al., 2017) and social isolation (Wilson et al., 2007); indicating that it is not 
the objective situation but rather the perceived absence of social attachments that increases 
risk of cognitive decline.  
 
Whilst the current literature adds to the evidence base for the association between 
loneliness and cognitive functioning among older adults, even after controlling for a range 
of demographic risk factors, it does not provide enough information to conclude upon the 
cause-effect relationship between these two variables. It may be those who are lonely are 
less cognitively stimulated. Alternatively, it is also possible that cognitive decline results in 
individuals withdrawing from their social world and having consequent increased feelings 
of loneliness. Future research is required to investigate these hypotheses.  
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Limitations and Implication for Future Research and Clinical Practice 
 
This review only included studies with participants aged 65 years and above, as this is the 
age of individuals being seen within older adult services offering input for age-related 
cognitive conditions. However, this did mean the exclusion of some relevant literature 
assessing the association between loneliness and cognitive function that included 
participants under 65 years. Also, the majority of studies included Western, European 
samples, limiting the generalisability of results.  
 
Future longitudinal research, which includes diverse cultures and settings, will help to 
explore the causal relationship between loneliness and cognitive function. Such studies 
should control for a range of demographic and risk factors thought to influence loneliness. 
In relation to this, further research is needed to explore the hypothesis that loneliness may 
be affecting pathways more proximal to cognitive function, such as depression.  Findings 
from such studies will help to shape policy and support the development of appropriate 
interventions to help decrease loneliness and improve cognitive function among older 
adults.  
 
This review has also highlighted that having social relationships that are perceived as 
meaningful (perhaps through having shared interests) seems to be crucial in decreasing 
feelings of loneliness, rather than the number of relationships in one’s social network. As 
such, interventions aimed to reduce loneliness should focus on providing the opportunity 
for older adults to develop a select number of close and emotionally supportive 
relationships. 
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Conclusions 
 
Overall, increased loneliness is associated with reduced cognitive function, particularly 
global cognitive function. Loneliness may therefore be an indicator of those at increased 
risk of cognitive decline and a potentially treatable risk factor for cognitive impairment in 
older adults. More longitudinal research is required to explore the causal relationship 
association between loneliness and cognitive function. 
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Plain English Summary 
 
An exploratory study of the “active ingredients” that lead to positive outcomes following 
cognitive stimulation therapy in dementia care 
 
Background: Cognitive stimulation therapy (CST) is an evidence-based, psychosocial 
group intervention, which aims to optimise cognitive function for persons with mild to 
moderate dementia. Whilst CST has been shown to enhance cognitive function and quality 
of life (QoL) of those with a dementia (Spector, Thorgrimsen, Woods et al., 2003), less is 
known about the “active ingredients” of CST that lead to such positive outcomes.  
CST focuses on fostering individual strengths and is carried out in a social group 
environment. As such, it may be that changes in QoL and cognition following participation 
in CST groups are related (in part) to an increase in social relationships and confidence in 
one’s ability to accomplish tasks.  
 
Loneliness and Social Relationships 
 
Several studies investigating social contexts and their association with mental health and 
well-being among older adults have shown that having better social relationships is 
protective against mental ill health (e.g. Chan et al., 2011). 
Older adults are especially likely to experience age-related losses that affect their social 
relationships. Individuals with dementia may have additional challenges making 
meaningful social connections due to increased difficulties with communication, 
increasing their risk of loneliness.  
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Confidence in Accomplishing Tasks 
 
 
One’s sense of confidence in their ability to succeed in a specific situation or accomplish a 
task can play a major role in how one approaches goals, tasks, and situations. Those with 
dementia experience a decline in independence and a significant loss of control in their 
lives, likely impacting upon their confidence.  
 
Aims: To explore if social relationships, loneliness and confidence in one’s ability to 
accomplish tasks improve for individuals following CST intervention. Also, to investigate 
if improvements in loneliness, social relationships and confidence in one’s ability to 
accomplish tasks are linked to positive outcomes found in cognition and QoL following 
participation in CST. 
 
Methods: Participants included older adults with a diagnosis of mild to moderate dementia 
who completed CST groups within Older People Community Mental Health Teams 
(OPCMHTs) across Greater Glasgow and Clyde. Participants were provided with 
information on the study by CST group organisers and were required to sign a consent 
form to take part. Participants completed measures assessing cognition, QoL, loneliness, 
social relationships and confidence in their ability to accomplish tasks prior to, during, and 
following completion of the CST group.  
 
Results: 22 participants took part in this study. Significant improvements for confidence in 
ability to accomplish tasks and QoL were found post CST. Improvement in QoL scores 
were associated with improved loneliness and confidence in accomplishing tasks scores 
post CST intervention.  
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Conclusions: Results suggest that confidence in accomplishing tasks improves following 
CST intervention, which is a new find. Also, improvements in QoL were associated with 
improvements in loneliness and confidence in accomplishing tasks scores following CST 
intervention. Future research needs to clarify the role of loneliness and confidence in 
accomplishing tasks in the context of outcomes for CST intervention.  
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Scientific Abstract 
 
 
Background: The efficacy and effectiveness of Cognitive Stimulation Therapy (CST) in 
improving cognition and quality of life (QoL) in individuals with dementia has been well 
demonstrated (e.g. Spector Thorgrimsen, Woods et al., 2003). However, less is known 
about the mechanisms of change for these positive outcomes.    
 
Objective: This study aimed to explore potential mechanisms of change for CST, 
including loneliness, social-connectedness and self-efficacy.  
 
Design: A within group repeated measure study was adopted. Participants included older 
adults with mild-moderate dementia participating in CST groups within Older People 
Community Mental Health Teams across Greater Glasgow and Clyde.  
 
Methods: Participants were asked to complete assessment measures on loneliness, social 
connectedness and self-efficacy prior to, during, and following CST intervention. 
Wilcoxon signed rank tests explored whether there were significant differences in outcome 
scores post CST. Spearman correlations examined the relationship between changes in 
cognition and QoL scores with changes in loneliness, social connectedness and self-
efficacy scores post CST.  
 
Results: Recruitment was lower than anticipated, with 22 participants recruited and 15 
completing pre and post assessments. A significant improvement for self-efficacy was 
found post CST. Improved QoL scores were associated with decreased loneliness and 
improved self-efficacy post CST.  
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Conclusions: There are suggestions within these preliminary findings that self-efficacy 
improves following CST, which is a novel finding. Results also revealed that 
improvements in QoL were associated with improvements in loneliness and self-efficacy 
following CST. However, the small sample size in this study means that conclusions that 
can be drawn are limited. Future research needs to clarify the role of loneliness and self-
efficacy in the context of outcomes for CST intervention.  
 
Key words: older adult, dementia, cognitive stimulation, social connectedness, self-efficacy 
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Introduction 
 
 
The ageing population is resulting in a disproportionate increase in the ‘older old’ i.e. those 
over the age of 85. As populations age, there is also an increase in age-related diseases 
such as dementia. Currently, there are around 47 million people with dementia worldwide, 
and this is projected to increase to 75 million by 2030 (WHO, 2017). As such, the need for 
effective and accessible treatments for dementia is paramount. 
 
 
Cognitive Stimulation Therapy 
 
 
Cognitive stimulation therapy (CST) is a brief, evidence-based, psychosocial group 
intervention, which aims to optimise cognitive function for persons with mild to moderate 
dementia. CST focuses on fostering individual strengths through themed sessions that 
incorporate therapeutic techniques such as reality orientation or reminiscence. Reality 
orientation is intended to facilitate memory through the presentation and repetition of 
information, that serves as factual reminders about the self or the environment (Douglas, 
James & Ballard, 2004). Reminiscence therapy involves discussion of past activities, 
events or experiences often using concrete prompts (Spector, Davies, Woods et al., 2000). 
Evidence shows CST enhances cognition and improves quality of life (QoL) of those with 
dementia (Knapp, Thorgrimsen, Patel et al., 2006; Spector, Thorgrimsen, Woods et al., 
2003). It is currently the only non-pharmacological intervention recommended to improve 
cognition for those with mild to moderate dementia (Nice, 2007). Whilst studies have 
evidenced the efficacy and effectiveness of CST, less attention has been paid to 
mechanisms of change.  
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Spector, Gardner & Orrell (2011) carried out a qualitative study of experiences of the 
people attending CST groups, carers and group facilitators. Themes from patients, carers 
and group facilitators indicate positive experience when commenting on the experience of 
patients in groups and changes in everyday life. In a recent RCT investigating 
individualised CST being delivered via patient family/carer dyads, results revealed this to 
be less effective, with no significant differences found for cognition or QoL (Orgeta, 
Leung, Kang et al., 2015). This suggests that the socially orientated group context of 
traditional CST may, in part, contribute to positive outcomes.  
 
Loneliness and Social Connectedness 
 
 
Studies investigating the association between social contexts and mental health and well-
being among older adults (OA) have shown that greater social connectedness is protective 
against mental ill health (e.g. Chan, Malhotra, Malhotra et al, 2011; Chao, 2011; Fiori, 
Antonucci, & Cortina, 2006). Research has also demonstrated the benefits of active 
engagement in social group activity upon cognitive function among older adults for a range 
of groups, including reminiscence groups (Haslam, 2010) and men’s clubs to reduce social 
isolation (Gleibs, Haslam, Haslam et al., 2011). This suggests that cognitive improvement, 
may result not from the specific content of the intervention, but rather the meaningful 
engagement in social group activity. As a result of cognitive impairment, people with 
dementia may be less able to sustain important social relationships than their healthy peers, 
with significant consequences for well-being and cognition. Indeed, social connectedness 
has been shown to be affected during the early stages of dementia (Hatch, 2013).  
 
From this, it could be argued that individuals with dementia are more likely to experience 
feelings of loneliness. Loneliness has been defined as “a distressing feeling that 
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accompanies the perception that one’s social needs are not being met by the quantity, or 
especially the quality of one’s social relationships” (Hawkley & Cacioppo, 2010, pp.218). 
As such, when considering social connectedness and loneliness, it seems important to 
focus on the individual’s perception of their social world, rather than for example focus on 
the objective number of social relationships or social contacts an individual has.   
 
Self-Efficacy 
 
 
Self-efficacy refers to a person’s belief in his or her ability to succeed in a specific 
situation or accomplish a specific task (Bandura, 1977). Higher general self-efficacy has 
been related to better QoL in patients with acquired brain injury (ABI) (Brands, Kohler, 
Stapert et al., 2014) as well as chronic conditions, such as chronic obstructive pulmonary 
disease (COPD) (Bentsen, Wentzel-Larsen, Henriksen et al., 2010). Symptoms of dementia 
lead to significant disruptions in social and occupational participation (American 
Psychiatric Association, 2013) and patients experience a tremendous loss of control in their 
lives.  
 
As mentioned above, CST focuses on fostering individual strengths and is carried out in a 
socially orientated context. As such, it may be that changes in QoL and cognition 
following participation in CST groups are related (in part) to an increase in social 
connectedness and self-efficacy and a decrease in feelings of loneliness.  
Aims  
 
To investigate whether there are changes in loneliness, social connectedness and self-
efficacy from pre-to post CST group, and whether changes in these variables are associated 
with changes in cognition and QoL.  
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Hypotheses 
(1) All outcome measure scores will significantly improve post CST intervention 
(2) Change scores in cognition measures will be associated with change scores in 
loneliness, social connectedness and self-efficacy measures 
(3) Change scores in QoL measures will be associated with change scores in 
loneliness, social connectedness and self-efficacy measures 
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Method 
 
Design  
 
 
A within group repeated measures design was adopted.  
 
Participants 
 
 
Participants included community-dwelling older people with a diagnosis of mild to 
moderate dementia. Participants were recruited by convenience sampling from those 
attending CST groups within five Older People Community Mental Health Teams 
(OPCMHTs) within Greater Glasgow and Clyde.  
 
Inclusion Criteria 
 
Inclusion criteria were based on the previous CST trial by Spector et al. (2003). This is 
also the current inclusion criteria for individuals attending clinical CST groups. These 
stipulated that participants (a) met the DSM-IV criteria for dementia (American Psychiatric 
Association, 1994), (b) scored between 10 and 24 on the Mini Mental State Examination 
(MMSE; Folstein, Folstein & McHugh, 1975), (c) had some ability to communicate and 
understand communication, with sufficient capacity to give informed consent to participate 
in the study (d) could see and hear well enough to participate in the group, (e) did not have 
a major physical illness or disability which compromised participation and (f) did not have 
a diagnosis of a learning disability. Both male and female participants were included, aged 
65 years and above.  
Exclusion Criteria 
People who lacked the capacity to consent in research were excluded.  
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Ethical Approval 
 
 
Ethical approval was obtained from the West of Scotland Research Ethics Committee No. 
3 (ref:17/WS/0188) (see Appendix 2.1) and R&D approval (ref: GN17MH460) was 
granted by NHS Greater Glasgow and Clyde (see Appendix 2.2). Informed consent was 
obtained from all participants. 
 
Procedure 
 
Recruitment 
 
 
Participants were identified by clinicians at five  OPCMHTs within NHS Greater Glasgow 
and Clyde health board and were provided with information on the study and a ‘opt’ in 
slip. Interest was expressed by participants by completing the ‘opt in’ slip and consent 
given for their contact details to be provided to the researcher. The researcher telephoned 
those interested and arranged appointments to go through a participant information sheet 
and obtain informed consent. Recruitment took place between October 2017 and June 
2018.  
 
CST Intervention 
 
 
CST intervention followed the protocol outlined in the RCT by Spector et al. (2003). This 
involved 14 structured 45-minute group therapy sessions, conducted twice weekly over a 
period of seven weeks, within participants’ local OPCMHT. The groups were conducted 
by trained CST facilitators within each OPCMHT.  
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Data Collection 
 
 
All groups were evaluated as per standard clinical practice within each OPCMHT using the 
Mini-Addenbrooke’s Cognitive Examination (m-Ace; Hsieh, McGory, Leslie et al., 2014) 
and QoL-Alzheimer’s Disease scale (QoL-AD; Logsdon, Gibbons, McCurry et al., 1999) 
pre and post CST intervention. The m-ACE is utilised within OPCMHTs instead of the 
MMSE for cognitive screening due to a change in licensing laws for the MMSE. Scores for 
these measures were recorded for participants in this study to assess the effectiveness of 
CST intervention. 
 
All participants were asked to complete measures for loneliness and self-efficacy pre and 
post CST intervention. A ‘group fit’ questionnaire for measuring participants’ social 
connectedness to the CST group was completed at the end of CST sessions 1, 7, and 14 in 
the presence of CST facilitators.  
 
Measures 
 
 
Selection of measures 
 
There is an absence of validated measures for people with dementia regarding social 
connectedness and self-efficacy. However, Mak (2011) has argued that we should not 
assume that scales which are not designed for people with dementia cannot be completed 
meaningfully by people with mild to moderate dementia. Moreover, the scales that have 
been selected for the current study are simple and feedback from a small number of 
individuals participating in a CST group in Inverclyde who volunteered to review the 
scales was that the measures were easy to understand and use, indicating they can be 
completed in a meaningful way by this client group.   
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Primary Outcome measures 
 
Loneliness  
 
The Three Item Loneliness Scale (Hughes, Waite, Hawkley et al., 2004) was also 
administered pre and post CST intervention. This scale is based on the UCLA Loneliness 
Scale (UCLA) (Russell, Peplau, & Ferguson, 1978), which has been widely used in 
loneliness research. The Three Item Loneliness Scale correlates strongly with the UCLA 
(r=0.82) and has high internal consistency with Cronbach’s alphas range from .89 to .94. 
Total scores range from 3-9. 
 
Social connectedness  
 
A measure of ‘group fit’ has been used in previous research with older adults participating 
in a reminiscence group (Haslam, Haslam, Ysseldyk, et al., 2014), and was used in the 
current study to assess participants’ perceived fit with their CST groups at the end of 
sessions 1, 7, 14 (See Appendix 2.4). This measure provides participants with a visual 
scale comprised of seven pairs of circles where one circle represented the participant and 
the other circle represented the group. At one end of the scale there was no overlap or ‘fit’ 
between circles (scored 1) and at the other extreme there was complete overlap (scored 7). 
Participants were asked to choose the pair of circles that best represented the fit between 
them and the group for that session. 
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Self-Efficacy 
 
The General Self-Efficacy scale (GSE) (Shwarze & Jerusalem, 1995) was created to assess 
a general sense of perceived self-efficacy with the aim of predicting coping with daily 
hassles as well as adaptation after experiencing stressful life events. It has been used with 
older people with dementia (Sprange, Mountain, Shortland et al, 2015). Cronbach’s alphas 
range from .76 to .90. Total scores range from 10-40. 
 
Secondary Outcome measures 
 
 
Cognition and QoL 
 
 
Within Spector et al. (2003), significantly improved scores for the CST group were found 
on the following measures of cognition and QoL - the MMSE (p=0.044, 95% CI 0.57-2.27, 
d=0.37) the Alzheimer’s Disease Assessment scales- Cognition scales (ADAS-COG; 
Rosen, Mohs, Davis et al., 1984) (p=0.014, 95% CI 0.64-4.09, d=0.37) and the QoL-
Alzheimer’s Disease scale (QoL-AD; Logsdon, Gibbons, McCurry et al., 1999) (p=0.028, 
95% CI 0.09-3.18, d=0.39).  
 
Currently, OPCMHTs running CST groups routinely assess the efficacy and effectiveness 
of CST using the m-Ace and QoL-AD; scores for routine outcome measures were recorded 
for participants. In addition, the researcher administered the ADAS-COG pre and post CST 
intervention to examine change following attending the CST group. See also Figure 1 for a 
summary of the procedure of the administration of outcome measures.  
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Figure 1: Procedure for the administration of outcome measures 
 
 
 
Sample Size 
 
There is no existing research literature regarding effect sizes for the primary outcome 
measures in similar studies. However, in their study, Spector et al. (2003) achieved small –
medium effect sizes on measures of cognition (d=0.37) and QoL (d=0.39). Using G Power 
(Faul, Erdfelder, Lang et al., 2007) a sample size of 47 would be required to detect an 
effect size of 0.37 using a within group t-test with a 0.05 (one-tailed) level of significance. 
As such, a sample size of 47 should have sufficient power to detect a change in outcome 
measures assessing QoL and cognition and was therefore set as the recruitment target for 
the current study.  A sample size of 47 would have sufficient power (0.8) to detect a 
correlation of 0.35, with alpha at 0.05.  
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Statistical Analysis 
 
Statistical analysis was undertaken using SPSS Statistics Version 21. Descriptive statistics 
provide information regarding baseline demographics of participants (see Table 1). 
Observation of box plots, showing medians and interquartile ranges on the data did not 
meet parametric assumptions. This coupled with the small sample size resulted in non-
parametric tests being used to analyse data. The Wilcoxon Signed Rank Test was used to 
compare pre and post CST intervention scores for all outcome measures. Spearman 
correlations were used to understand the relationship between changes in cognition and 
QoL with changes in loneliness, social connectedness and self-efficacy following CST 
intervention.  
 
Information regarding recruitment, retention and outcome measure completion rates are 
reported to provide indications of feasibility for future studies (see Figure 2). Additional 
analysis was also carried out to determine if there was a significant difference in baseline 
demographics and outcome measure scores for those who completed CST intervention and 
therefore post assessment, and those who did not. Fisher’s exact and Mann-Whitney U 
tests were used for this.  
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Results 
 
 
A total of 22 participants were recruited to this study. Information regarding the number of 
CST groups facilitated across five OPCMHTs within GG&C in a ten month period, and 
recruitment and retention rates of participants for the current study are reported in Figure 2. 
Post assessments were not completed for seven participants due to them dropping out of 
CST intervention. There was missing baseline data for the ADAS-Cog for one participant 
who later dropped out of CST, this was due to eye sight difficulties that prevented them 
from completing this measure. Out of the fifteen people who completed post assessments, 
there was missing data for one participant’s group fit measure for CST session 14 due to 
them not attending this session.  
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Figure 2: Numbers in CST intervention and recruitment and retention rates for participants  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of completed post assessments 
15 
Number in CST intervention 
75 
Those approached to take part in study 
52 
Those who consented 
23 
Number of completed pre assessments 
22 
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The median age of the 22 participants recruited to this study was 79 years, and participants 
had a median of 10 years of education. The Scottish Index of Multiple Deprivation (SIMD) 
categorises levels of deprivation based on postal codes into quintiles 1 (highest level of 
deprivation) to 5 (lowest level of deprivation). SIMD for participants is presented here as 
Low Deprivation and High deprivation based on quintile scores. Table 1 displays the 
baseline demographic information of participants recruited to this study as well as SIMD 
quintiles. 
 
Table 1: Participant Baseline Demographic Information  
Variable Participants (N=22) 
Age Mdn      (IQR) 
79         (76, 81) 
Years of Education Mdn      (IQR) 
10         (10, 10) 
SIMD Quintile 
Low Deprivation (n, %) 
High deprivation (n, %) 
 
6           (27.3%) 
16         (72.7%) 
Gender 
Female (n, %) 
Male     (n, %) 
 
13        (59.1%) 
9          (40.9%) 
Note: Scottish Index of Multiple Deprivation (SIMD), Low Deprivation = Quintiles 3-5; High 
Deprivation = Quintiles 1-2 
 
Hypothesis 1: All outcome measure scores will significantly improve post CST intervention 
 
A Wilcoxon signed-rank test revealed a statistically significant increase in QoL-AD scores 
from pre (Mdn=34) to post (Mdn=37; Z=-2.209, p<0.05, r=.36) and in General Self-
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Efficacy scores from pre (Mdn=29.50) to post (34; Z=-2.012, p<0.05, r=.33), with medium 
effect sizes for both. See Table 2 for details.  
Table 2: Difference in outcome measure scores post CST intervention 
 Pre  
Median 
(IQR) 
 
Post 
Median 
(IQR) 
Z statistic Significance Effect size 
Pearson’s r 
m-ACE 16.50 
(11.75, 21) 
18.50 (13, 
25) 
.634 p=.526 0.10 
QoL AD 34 (30.75, 
40) 
37(33, 40) -2.209 p=.027* -0.36 
ADAS Cog 10 (8, 14) 9 (8, 13) -.322 p=.747 -0.05 
Loneliness Scale 4 (3, 5) 3 (3, 4) -1.681 p=.093 -0.28 
Group Fit 7 (6, 7) 7 (7, 7) -1.725 p=.084 -0.30 
GSE 29.50 
(25.50, 
33.75)  
34 (27, 35) -2.012 p=.044* -0.33 
Note: General Self-Efficacy (GSE), * Indicates significance of p<0.05 
 
Hypothesis 2: Change scores in cognition will be associated with change scores in 
loneliness, social connectedness, and general self-efficacy 
 
Given the absence of change scores in cognition following CST intervention, the testing of 
hypothesis 2 is redundant.  
Hypothesis 3: Change scores in QoL will be associated with change scores in loneliness, 
social connectedness, and self-efficacy. 
 
Correlations between outcome measures based on change scores are reported in Table 3. 
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Change scores for QoL were significantly correlated with change scores for loneliness (r=-
0.59, n=15, p=0.01) and self-efficacy (r=0.49, n=15, p=0.03). Improvements with 
loneliness and self-efficacy were associated with improvements in QoL post CST 
intervention. 
 
Table 3: Spearman correlations between outcome measures based on change scores post CST 
 QoL-AD 
r 
Loneliness 
r 
Group Fit 
r 
GSE 
r 
QoL-AD 1 -0.59* 0.04 -0.49* 
Loneliness -0.59* 1 0.24 -0.18 
Group Fit 0.00 0.24 1 0.11 
GSE 0.49* -0.18 0.11 1 
Note: General Self-Efficacy (GSE), *Correlation is significant at the 0.05 level (one tailed) 
 
Additional Analysis 
 
All demographics and baseline outcome measure scores were tested for differences 
between completers and non-completers of CST intervention. Fisher’s exact and Mann-
Whitney U tests were used to compare data. Measures of effect sizes are also reported (see 
Tables 4 and 5). A Mann-Whitney U test revealed a significant difference in age between 
completers (Mdn=80, n=15) and non-completers (Mdn=74, n=7; U=21, Z=-2.00, p=.046, 
r=0.19). A significant difference was also found for m-ACE scores between completers 
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(Mdn=17, n=15) and non-completers (Mdn=12, n=7; U=21, Z=-2.00, p=.046, r=.19) and 
for general self-efficacy scores between completers (Mdn=28, n=15) and non-completers 
(Mdn=37, n=7; U=14, Z=-2.51, p=.012, r=.30).  
 
 
Table 4: Baseline age, years of education, and scores on measures for completers and non completers 
of CST 
 Completers 
Mdn (IQR)  
Non-
Completers 
Mdn (IQR) 
Z statistic Significance Effect Size 
Pearson’s r 
Age 80 (78, 81.50) 74 (73, 75) -2.00 p=0.046* 0.19 
Years of 
Education 
10 (10, 10) 10 (9.50, 
10.50) 
-0.78 p=0.438 0.03 
m-ACE 17 (13.50, 
21.50) 
12 (9.50, 
16.50) 
-2.00 p=0.046* 0.19 
QoL-AD 34 (30.50, 
37.50) 
37 (34, 42) -1.49 p=0.137 0.11 
ADAS Cog 8 (8, 12.50) 11 (10, 15) -1.46 p=0.144 0.11 
Loneliness 4 (3, 5) 4.50 (3, 6) -0.27 p=0.785 0.00 
GSE 28 (25, 32.50) 37 (33, 38) -2.51 p=0.012* 0.30 
Group Fit 7 (6, 7) 7 (6, 7) -1.28 p=0.202 0.10 
General Self-Efficacy (GSE), *Significant difference at the p<0.05 level (two tailed) based on 3d.p 
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Table 5: Gender and level of deprivation among completers and non completers of CST 
 
Variable Completers 
(n=15) (%) 
Non-Completers 
(n=5) (%) 
Significance Effect Size 
Cramer’s V 
Gender 
Female 
Male 
 
9 (69.2) 
7 (77.8) 
 
4 (30.8) 
2 (22.2) 
 
 
p=1.0 
 
 
0.66 
SIMD 
Low Deprivation 
High Deprivation 
 
5 (83.3) 
11 (68.8) 
 
1 (16.7) 
5 (31.3) 
 
 
p=0.63 
 
 
0.15 
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Discussion 
 
This study aimed to explore possible mechanisms of change for positive outcomes found in 
CST intervention. This is important in order to better match participants to intervention 
and also help inform the development of other interventions for dementia. Of note, the 
results of the current study are based on a sample of participants with high levels of 
deprivation and relatively low levels of education.  The results revealed that quality of life 
and self-efficacy significantly improved pre to post CST intervention, providing some 
support for the hypothesis that these outcome variables would improve post CST (H1). 
Results also revealed change scores in QoL to be associated with change scores in 
loneliness and self-efficacy following the CST intervention, providing some support for 
H3. However, no support was provided for H2, in that change cognition scores were not 
associated with change scores for loneliness, social connectedness, or self-efficacy 
following CST intervention.  
 
Outcome Measures  
 
 
Results revealed that participants’ quality of life significantly improved post CST 
intervention. When exploring descriptive statistics, there were also trends that cognitive 
function marginally improved for participants post CST intervention (as measured by m-
ACE and ADAS-Cog). These findings are partially in line with previous studies 
investigating effectiveness of CST (Spector et al., 2003). The more marginal effects found 
in this study of improved cognitive function following CST intervention may be due to the 
small sample size, which resulted in this study being under powered. Of note, previous 
studies investigating the effectiveness of CST did not control for years of education or 
levels of deprivation among participants. This study included a sample of participants with 
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high levels of deprivation and relatively low levels of education and it may be that this also 
contributed to the marginal effects for positive change for cognition post CST intervention.    
 
This study also found that self-efficacy significantly improved post CST intervention, 
indicating that CST had a positive impact among participants’ belief in their abilities to 
succeed in situations and/or accomplish tasks. This is the first study to report a finding of 
improved self-efficacy following CST intervention.  
 
Descriptive statistics indicate that there was a slight decrease in loneliness scores for 
participants post CST intervention, indicating some support that loneliness decreased post 
CST intervention, though this did not reach statistical significance. Social connectedness 
(as assessed by the group fit measure) remained stable pre to post CST intervention.  
 
When observing raw scores for the group fit measure, participants appear to have rated 
social connectedness to CST group as high at the end of CST sessions 1, 7 and 14. CST 
facilitators, rather than an independent researcher, administered the group fit measure to 
participants. As such, there could be increased risk that participants were rating social 
connectedness to CST group as high at baseline due to social desirability bias among 
participants.  
 
Understanding of Mechanisms of Change 
 
 
Future studies with larger sample sizes will be able to better examine the mediators of any 
positive outcomes following CST intervention. In the meantime, the quantitative analysis 
completed here provides some support for H3, in that there were associations between 
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change scores for QoL with change scores for loneliness and self-efficacy following CST 
intervention.  
 
The finding that improved self-efficacy is associated with improved QoL for dementia 
patients following CST intervention, is in line with research demonstrating higher general 
self-efficacy is related to better QoL for people with acquired brain injury (ABI) (Brands et 
al., 2014) as well as chronic health conditions, such as COPD (Bentsen et al., 2010). This 
provides support for the idea that, in addition to improving cognition and QoL, CST may 
help to increase individuals’ sense of belief in themselves. This may be particularly 
important in the context of individuals having dementia, which results in disruptions to 
social and occupational participation, and a resultant experience of loss of control in one’s 
life.  
 
The finding that decreased loneliness was associated with increased QoL following CST 
intervention is in line with previous research highlighting the importance of social 
wellbeing to more general perceptions of wellbeing (e.g. Haslam, Haslam, Jetten et al. 
2010).  
 
The fact that there were no missing items on outcome measures that were completed for 
loneliness, social connectedness, and self-efficacy indicate the acceptability and feasibility 
of these measures for future studies. A larger scale study utilising these measures may be 
able to provide more definitive evidence of the possible associations between loneliness, 
social connectedness and self-efficacy and positive outcomes found post CST intervention.  
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Recruitment and Attrition Rates 
 
 
Recruitment was lower than anticipated, resulting in this study being underpowered to 
detect some hypothesised effects. Low recruitment was due to a number of factors. Some 
OPCMHTs were not running as many CST groups as typical during the ten month 
recruitment period because of staff absences. Of the CST groups that were running, a 
number of older people were not approached about participating in the study. This was 
partly due to CST facilitators forgetting to speak to individuals about taking part in the 
study during the screening stage for CST intervention. Also, those individuals who 
appeared anxious during the screening process for CST were not approached about the 
research, as it was felt this may unnecessarily add to their anxieties about attending the 
CST intervention.  
 
Less than half of those approached to participate in the study consented. Of those who 
consented to take part in the study, one individual did not go onto complete pre-assessment 
due to them no longer wishing to engage in the CST intervention. Seven of those who 
completed pre-assessments did not complete the CST intervention, resulting in post CST 
assessments not being carried out for these participants.  
 
Statistical analysis of demographic and baseline data revealed that the ‘older old’ with 
better cognitive function (as measured by mACE) and lower self-efficacy were 
significantly more likely to complete CST intervention. Studies with larger sample sizes 
may wish to explore if the ‘older old’ with better cognitive functioning and lower self-
efficacy at baseline benefit more from CST intervention than others.  
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Strengths and Limitations 
 
 
Strengths of this study include the usefulness of feasibility information for future research 
aiming to explore mechanisms of change for positive outcomes found following CST 
intervention. As discussed previously, loneliness and social connectedness are multifaceted 
concepts reflecting one’s subjective experience of relationships and social network. As 
such the use of two subjective self-report measures to assess loneliness and social 
connectedness was a strength of this study. A small number of patients receiving CST 
intervention were involved in helping to determine the outcome measures for loneliness, 
social connectedness, and self-efficacy used for this study, to help assure the ease of 
completion of these measures within this population. There were no missing items on these 
outcome measures completed by participants, also indicating their feasibility for future 
studies.  
 
The main limitation of this study was the low participant numbers, resulting in this study 
being under-powered to detect some effects and limiting the conclusions that could be 
drawn. Depression has often been cited as part of the explanatory pathway between social 
resources and later health outcomes, including cognitive function. However, depressive 
symptoms of participants were not assessed within this study.  
 
The group fit measure, assessing social connectedness to CST group, was administered to 
participants by CST facilitators rather than a researcher. It is possible that the results 
obtained from this measure may have been over-estimated by bias introduced via social 
desirability.    
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Future Research 
 
 
There remains a lack of non-pharmacological treatments for dementia, particularly when 
considering the population prevalence. As such, understanding the potential underlying 
mechanisms of change for positive outcomes found in CST remains a priority, as it should 
more effectively match patients to this intervention as well as direct the development of 
further interventions for dementia care. This study has indicated difficulties with 
recruitment and retention of participants attending CST. Future studies should consider this 
when aiming for a larger sample size to ensure appropriate power. In relation to this, effect 
size was larger than anticipated within the current study, but caution is required given the 
small sample size. If the effect size is accurate, a sample of 22 participants would be 
sufficient to detect a significant difference. Given the dropout rate of 31.8% in the current 
study, a sample of at least 29 participants would be required for future research. Future 
studies should also consider an independent researcher administering any social 
connectedness measures when assessing participants’ social connectedness to CST group 
to reduce risk of social desirability bias. Finally, future larger studies should explore if 
years of education and levels of deprivation impact upon positives outcomes found for 
cognition following CST intervention.  
 
Conclusions 
 
 
Overall, the findings of this study are limited due to small sample size, which resulted in 
the study being underpowered. There are, however, new suggestions within these 
preliminary findings that self-efficacy improves following CST intervention, in addition to 
QoL and cognitive function. Associations between improvements in QoL with loneliness 
and self-efficacy require further exploration, and replication. Future research needs to 
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clarify the role of loneliness and self-efficacy in the context of outcomes for CST 
intervention.  
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Appendix 1.2. Table for Axis and Covariates Controlled for within Studies 
 
Conroy et al. (2010) 
 
 Yes/No/Don’t know (Y/N/DK) Comments 
Study Design Quality 
Was the study design appropriate for the stated aims? Y  
Was the sample size justified? N  
Was the sample frame taken from an appropriate population base so 
that it closely represented the target/reference population under 
investigation? 
Y  
Were the risk factor and outcome variables measured appropriate to 
the aims of the study? 
Y  
Were the authors’ discussions and conclusions justified by the 
results? 
Y  
Were there any funding sources or conflicts of interest that may 
affect the authors’ interpretation of the results? 
N  
Was ethical approval or consent of participants attained? Y  
Risk of Biases 
Was the selection process likely to select subjects/participants that 
were representative of the target/reference population under 
investigation? 
Y  
Were measures undertaken to address and categorise on-responders N  
Were the risk factor and outcome variables measured correctly using 
instruments/measurements that had been trialled, piloted or 
published previously? 
N  
Does the response rate raise concerns about non-response bias? Y RR Not reported 
If appropriate, was information about non-responders described? N  
Were the results internally consistent? N Table 1 n=709, versus 
sample N= 802 
Quality of Reporting 
Were the aims/objectives of the study clear? Y  
Was the target/reference population clearly defined? Y  
Is it clear what was used to determine statistical significance and/or 
precision estimates? 
Y  
Were the methods (including statistical methods) sufficiently 
described to enable them to be repeated? 
Y  
Were the basic data adequately described? Y  
Were the results presented for all the analysis described in the 
methods? 
Y  
Were the limitations of the study discussed? N Nothing regarding non-
responders 
Covariates Age, Education 
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Donovan et al. (2017) 
 
 Yes/No/Don’t know (Y/N/DK) Comments 
Study Design Quality 
Was the study design appropriate for the stated aims? Y  
Was the sample size justified? N  
Was the sample frame taken from an appropriate population base so 
that it closely represented the target/reference population under 
investigation? 
Y  
Were the risk factor and outcome variables measured appropriate to 
the aims of the study? 
Y  
Were the authors’ discussions and conclusions justified by the 
results? 
Y  
Were there any funding sources or conflicts of interest that may 
affect the authors’ interpretation of the results? 
N  
Was ethical approval or consent of participants attained? DK Not mentioned 
Risk of Biases 
Was the selection process likely to select subjects/participants that 
were representative of the target/reference population under 
investigation? 
Y  
Were measures undertaken to address and categorise on-responders Y  
Were the risk factor and outcome variables measured correctly using 
instruments/measurements that had been trialled, piloted or 
published previously? 
N  
Does the response rate raise concerns about non-response bias? Y  
If appropriate, was information about non-responders described? Y  
Were the results internally consistent? Y  
Quality of Reporting 
Were the aims/objectives of the study clear? Y  
Was the target/reference population clearly defined? Y  
Is it clear what was used to determine statistical significance and/or 
precision estimates? 
Y  
Were the methods (including statistical methods) sufficiently 
described to enable them to be repeated? 
Y  
Were the basic data adequately described? Y  
Were the results presented for all the analysis described in the 
methods? 
Y  
Were the limitations of the study discussed? Y  
Covariates Age, Gender, Race, Education, Household Wealth, 
Household Income, Social Network, Physical Health, 
Depression 
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Gilmour (2011) 
 
 Yes/No/Don’t know (Y/N/DK) Comments 
Study Design Quality 
Was the study design appropriate for the stated aims? Y  
Was the sample size justified? N  
Was the sample frame taken from an appropriate population base so 
that it closely represented the target/reference population under 
investigation? 
Y  
Were the risk factor and outcome variables measured appropriate to 
the aims of the study? 
Y  
Were the authors’ discussions and conclusions justified by the 
results? 
Y  
Were there any funding sources or conflicts of interest that may 
affect the authors’ interpretation of the results? 
N  
Was ethical approval or consent of participants attained? DK Not mentioned 
Risk of Biases 
Was the selection process likely to select subjects/participants that 
were representative of the target/reference population under 
investigation? 
Y  
Were measures undertaken to address and categorise on-responders Y Sampling weights 
Were the risk factor and outcome variables measured correctly using 
instruments/measurements that had been trialled, piloted or 
published previously? 
DK Appears to use UCLA 
Loneliness scale but 
does not call it this 
Does the response rate raise concerns about non-response bias? N  
If appropriate, was information about non-responders described? N  
Were the results internally consistent? DK Unclear as no ‘N’ 
reported 
Quality of Reporting 
Were the aims/objectives of the study clear? Y Not in abstract, but in 
introduction 
Was the target/reference population clearly defined? Y  
Is it clear what was used to determine statistical significance and/or 
precision estimates? 
Y Yes for p values but not 
for confidence intervals 
Were the methods (including statistical methods) sufficiently 
described to enable them to be repeated? 
N  
Were the basic data adequately described? N  
Were the results presented for all the analysis described in the 
methods? 
Y  
Were the limitations of the study discussed? N  
Covariates Age, Gender, Education 
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Gow et al. (2013) 
 
 Yes/No/Don’t know (Y/N/DK) Comments 
Study Design Quality 
Was the study design appropriate for the stated aims? Y  
Was the sample size justified? N  
Was the sample frame taken from an appropriate population base so 
that it closely represented the target/reference population under 
investigation? 
Y  
Were the risk factor and outcome variables measured appropriate to 
the aims of the study? 
Y  
Were the authors’ discussions and conclusions justified by the 
results? 
Y  
Were there any funding sources or conflicts of interest that may 
affect the authors’ interpretation of the results? 
N  
Was ethical approval or consent of participants attained? Y  
Risk of Biases 
Was the selection process likely to select subjects/participants that 
were representative of the target/reference population under 
investigation? 
Y  
Were measures undertaken to address and categorise non-
responders 
N  
Were the risk factor and outcome variables measured correctly using 
instruments/measurements that had been trialled, piloted or 
published previously? 
N  
Does the response rate raise concerns about non-response bias? DK  
If appropriate, was information about non-responders described? N  
Were the results internally consistent? Y  
Quality of Reporting 
Were the aims/objectives of the study clear? Y  
Was the target/reference population clearly defined? Y  
Is it clear what was used to determine statistical significance and/or 
precision estimates? 
Y  
Were the methods (including statistical methods) sufficiently 
described to enable them to be repeated? 
Y  
Were the basic data adequately described? Y  
Were the results presented for all the analysis described in the 
methods? 
Y  
Were the limitations of the study discussed? Y  
Covariates Age 11-IQ, Age, Gender, Social Class, Depression 
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Gow & Mortensen (2016) 
 
 Yes/No/Don’t know (Y/N/DK) Comments 
Study Design Quality 
Was the study design appropriate for the stated aims? Y  
Was the sample size justified? N  
Was the sample frame taken from an appropriate population base so 
that it closely represented the target/reference population under 
investigation? 
Y  
Were the risk factor and outcome variables measured appropriate to 
the aims of the study? 
Y  
Were the authors’ discussions and conclusions justified by the 
results? 
Y  
Were there any funding sources or conflicts of interest that may 
affect the authors’ interpretation of the results? 
N  
Was ethical approval or consent of participants attained? Y  
Risk of Biases 
Was the selection process likely to select subjects/participants that 
were representative of the target/reference population under 
investigation? 
Y  
Were measures undertaken to address and categorise non-
responders 
N  
Were the risk factor and outcome variables measured correctly using 
instruments/measurements that had been trialled, piloted or 
published previously? 
N  
Does the response rate raise concerns about non-response bias? N  
If appropriate, was information about non-responders described? N  
Were the results internally consistent? N Participants = N wrong 
for age 70, age 80  
Quality of Reporting 
Were the aims/objectives of the study clear? Y  
Was the target/reference population clearly defined? Y  
Is it clear what was used to determine statistical significance and/or 
precision estimates? 
Y  
Were the methods (including statistical methods) sufficiently 
described to enable them to be repeated? 
Y  
Were the basic data adequately described? N Referred to in another 
paper 
Were the results presented for all the analysis described in the 
methods? 
Y  
Were the limitations of the study discussed? Y  
Covariates Sex, Education, Social Class 
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Gow et al. (2007) 
 
 Yes/No/Don’t know (Y/N/DK) Comments 
Study Design Quality 
Was the study design appropriate for the stated aims? Y Although much of 
analysis cross-sectional 
Was the sample size justified? N  
Was the sample frame taken from an appropriate population base so 
that it closely represented the target/reference population under 
investigation? 
Y  
Were the risk factor and outcome variables measured appropriate to 
the aims of the study? 
Y  
Were the authors’ discussions and conclusions justified by the 
results? 
Y  
Were there any funding sources or conflicts of interest that may 
affect the authors’ interpretation of the results? 
N  
Was ethical approval or consent of participants attained? DK Not mentioned 
Risk of Biases 
Was the selection process likely to select subjects/participants that 
were representative of the target/reference population under 
investigation? 
Y  
Were measures undertaken to address and categorise non-
responders 
N  
Were the risk factor and outcome variables measured correctly using 
instruments/measurements that had been trialled, piloted or 
published previously? 
N  
Does the response rate raise concerns about non-response bias? N  
If appropriate, was information about non-responders described? N  
Were the results internally consistent? Y  
Quality of Reporting 
Were the aims/objectives of the study clear? Y Not in abstract, but in 
introduction 
Was the target/reference population clearly defined? Y  
Is it clear what was used to determine statistical significance and/or 
precision estimates? 
Y  
Were the methods (including statistical methods) sufficiently 
described to enable them to be repeated? 
Y  
Were the basic data adequately described? N  
Were the results presented for all the analysis described in the 
methods? 
Y  
Were the limitations of the study discussed? Y  
Covariates Sex, Education, Social Class, Age-11 IQ 
 
 
 
 
 80 
Holmen et al. (1992) 
 
 Yes/No/Don’t know (Y/N/DK) Comments 
Study Design Quality 
Was the study design appropriate for the stated aims? Y  
Was the sample size justified? N  
Was the sample frame taken from an appropriate population base so 
that it closely represented the target/reference population under 
investigation? 
Y  
Were the risk factor and outcome variables measured appropriate to 
the aims of the study? 
Y  
Were the authors’ discussions and conclusions justified by the 
results? 
Y  
Were there any funding sources or conflicts of interest that may 
affect the authors’ interpretation of the results? 
N  
Was ethical approval or consent of participants attained? DK Not mentioned 
Risk of Biases 
Was the selection process likely to select subjects/participants that 
were representative of the target/reference population under 
investigation? 
Y  
Were measures undertaken to address and categorise non-
responders 
N  
Were the risk factor and outcome variables measured correctly using 
instruments/measurements that had been trialled, piloted or 
published previously? 
N  
Does the response rate raise concerns about non-response bias? DK Not clear 
If appropriate, was information about non-responders described? N  
Were the results internally consistent? DK No ‘N’ Value 
Quality of Reporting 
Were the aims/objectives of the study clear? Y  
Was the target/reference population clearly defined? Y  
Is it clear what was used to determine statistical significance and/or 
precision estimates? 
Y  
Were the methods (including statistical methods) sufficiently 
described to enable them to be repeated? 
N  
Were the basic data adequately described? N  
Were the results presented for all the analysis described in the 
methods? 
Y  
Were the limitations of the study discussed? N  
Covariates - 
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Holwerda et al. (2014) 
 
 Yes/No/Don’t know (Y/N/DK) Comments 
Study Design Quality 
Was the study design appropriate for the stated aims? Y  
Was the sample size justified? N  
Was the sample frame taken from an appropriate population base so 
that it closely represented the target/reference population under 
investigation? 
Y  
Were the risk factor and outcome variables measured appropriate to 
the aims of the study? 
Y  
Were the authors’ discussions and conclusions justified by the 
results? 
Y  
Were there any funding sources or conflicts of interest that may 
affect the authors’ interpretation of the results? 
N  
Was ethical approval or consent of participants attained? Y  
Risk of Biases 
Was the selection process likely to select subjects/participants that 
were representative of the target/reference population under 
investigation? 
Y  
Were measures undertaken to address and categorise non-
responders 
Y  
Were the risk factor and outcome variables measured correctly using 
instruments/measurements that had been trialled, piloted or 
published previously? 
N  
Does the response rate raise concerns about non-response bias? N  
If appropriate, was information about non-responders described? N  
Were the results internally consistent? Y  
Quality of Reporting 
Were the aims/objectives of the study clear? Y  
Was the target/reference population clearly defined? Y  
Is it clear what was used to determine statistical significance and/or 
precision estimates? 
Y  
Were the methods (including statistical methods) sufficiently 
described to enable them to be repeated? 
Y  
Were the basic data adequately described? Y  
Were the results presented for all the analysis described in the 
methods? 
Y  
Were the limitations of the study discussed? Y  
Covariates Depression, Gender, Age, Physical Health, Social 
Isolation, Education 
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O’Luanaigh et al. (2012) 
 
 Yes/No/Don’t know (Y/N/DK) Comments 
Study Design Quality 
Was the study design appropriate for the stated aims? Y  
Was the sample size justified? N  
Was the sample frame taken from an appropriate population base so 
that it closely represented the target/reference population under 
investigation? 
Y  
Were the risk factor and outcome variables measured appropriate to 
the aims of the study? 
Y  
Were the authors’ discussions and conclusions justified by the 
results? 
Y  
Were there any funding sources or conflicts of interest that may 
affect the authors’ interpretation of the results? 
N  
Was ethical approval or consent of participants attained? Y  
Risk of Biases 
Was the selection process likely to select subjects/participants that 
were representative of the target/reference population under 
investigation? 
Y  
Were measures undertaken to address and categorise non-
responders 
N  
Were the risk factor and outcome variables measured correctly using 
instruments/measurements that had been trialled, piloted or 
published previously? 
Y  
Does the response rate raise concerns about non-response bias? Y  
If appropriate, was information about non-responders described? N  
Were the results internally consistent? Y  
Quality of Reporting 
Were the aims/objectives of the study clear? Y  
Was the target/reference population clearly defined? Y  
Is it clear what was used to determine statistical significance and/or 
precision estimates? 
Y  
Were the methods (including statistical methods) sufficiently 
described to enable them to be repeated? 
Y  
Were the basic data adequately described? N N value missing 
Were the results presented for all the analysis described in the 
methods? 
Y  
Were the limitations of the study discussed? Y  
Covariates Social Network, Depression, Age, Gender, Social Class, 
Education, Marital Status 
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Stessman et al. (1996) 
 
 Yes/No/Don’t know (Y/N/DK) Comments 
Study Design Quality 
Was the study design appropriate for the stated aims? Y  
Was the sample size justified? N  
Was the sample frame taken from an appropriate population base so 
that it closely represented the target/reference population under 
investigation? 
Y  
Were the risk factor and outcome variables measured appropriate to 
the aims of the study? 
Y  
Were the authors’ discussions and conclusions justified by the 
results? 
Y  
Were there any funding sources or conflicts of interest that may 
affect the authors’ interpretation of the results? 
N  
Was ethical approval or consent of participants attained? DK Not mentioned 
Risk of Biases 
Was the selection process likely to select subjects/participants that 
were representative of the target/reference population under 
investigation? 
Y  
Were measures undertaken to address and categorise non-
responders 
Y  
Were the risk factor and outcome variables measured correctly using 
instruments/measurements that had been trialled, piloted or 
published previously? 
N  
Does the response rate raise concerns about non-response bias? N  
If appropriate, was information about non-responders described? Y  
Were the results internally consistent? Y  
Quality of Reporting 
Were the aims/objectives of the study clear? Y  
Was the target/reference population clearly defined? Y  
Is it clear what was used to determine statistical significance and/or 
precision estimates? 
Y  
Were the methods (including statistical methods) sufficiently 
described to enable them to be repeated? 
N No mention of what 
test was used to assess 
cognitive function 
Were the basic data adequately described? N N of female / male 
participants not 
reported 
Were the results presented for all the analysis described in the 
methods? 
Y  
Were the limitations of the study discussed? N  
Covariates - 
 
 
 84 
 
Tijhuis et al. (1999) 
 
 Yes/No/Don’t know (Y/N/DK) Comments 
Study Design Quality 
Was the study design appropriate for the stated aims? Y  
Was the sample size justified? N  
Was the sample frame taken from an appropriate population base so 
that it closely represented the target/reference population under 
investigation? 
Y  
Were the risk factor and outcome variables measured appropriate to 
the aims of the study? 
Y  
Were the authors’ discussions and conclusions justified by the 
results? 
Y  
Were there any funding sources or conflicts of interest that may 
affect the authors’ interpretation of the results? 
N  
Was ethical approval or consent of participants attained? DK Not mentioned 
Risk of Biases 
Was the selection process likely to select subjects/participants that 
were representative of the target/reference population under 
investigation? 
Y  
Were measures undertaken to address and categorise non-
responders 
N  
Were the risk factor and outcome variables measured correctly using 
instruments/measurements that had been trialled, piloted or 
published previously? 
Y  
Does the response rate raise concerns about non-response bias? N  
If appropriate, was information about non-responders described? N  
Were the results internally consistent? Y  
Quality of Reporting 
Were the aims/objectives of the study clear? Y  
Was the target/reference population clearly defined? Y  
Is it clear what was used to determine statistical significance and/or 
precision estimates? 
Y  
Were the methods (including statistical methods) sufficiently 
described to enable them to be repeated? 
Y  
Were the basic data adequately described? N  
Were the results presented for all the analysis described in the 
methods? 
Y  
Were the limitations of the study discussed? N  
Covariates - 
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Tilvis et al. (2004) 
 
 Yes/No/Don’t know (Y/N/DK) Comments 
Study Design Quality 
Was the study design appropriate for the stated aims? Y  
Was the sample size justified? N  
Was the sample frame taken from an appropriate population base so 
that it closely represented the target/reference population under 
investigation? 
Y  
Were the risk factor and outcome variables measured appropriate to 
the aims of the study? 
Y  
Were the authors’ discussions and conclusions justified by the 
results? 
Y  
Were there any funding sources or conflicts of interest that may 
affect the authors’ interpretation of the results? 
N  
Was ethical approval or consent of participants attained? Y  
Risk of Biases 
Was the selection process likely to select subjects/participants that 
were representative of the target/reference population under 
investigation? 
Y  
Were measures undertaken to address and categorise non-
responders 
N  
Were the risk factor and outcome variables measured correctly using 
instruments/measurements that had been trialled, piloted or 
published previously? 
Y  
Does the response rate raise concerns about non-response bias? Y Attrition at 10 year 
follow up 
If appropriate, was information about non-responders described? N  
Were the results internally consistent? Y  
Quality of Reporting 
Were the aims/objectives of the study clear? Y  
Was the target/reference population clearly defined? Y  
Is it clear what was used to determine statistical significance and/or 
precision estimates? 
Y  
Were the methods (including statistical methods) sufficiently 
described to enable them to be repeated? 
Y  
Were the basic data adequately described? Y  
Were the results presented for all the analysis described in the 
methods? 
Y  
Were the limitations of the study discussed? N  
Covariates - 
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Tzang et al. (2015) 
 
 Yes/No/Don’t know (Y/N/DK) Comments 
Study Design Quality 
Was the study design appropriate for the stated aims? Y  
Was the sample size justified? N  
Was the sample frame taken from an appropriate population base so 
that it closely represented the target/reference population under 
investigation? 
N Veteran housing 
Were the risk factor and outcome variables measured appropriate to 
the aims of the study? 
Y  
Were the authors’ discussions and conclusions justified by the 
results? 
Y  
Were there any funding sources or conflicts of interest that may 
affect the authors’ interpretation of the results? 
N  
Was ethical approval or consent of participants attained? Y  
Risk of Biases 
Was the selection process likely to select subjects/participants that 
were representative of the target/reference population under 
investigation? 
N  
Were measures undertaken to address and categorise non-
responders 
N  
Were the risk factor and outcome variables measured correctly using 
instruments/measurements that had been trialled, piloted or 
published previously? 
Y  
Does the response rate raise concerns about non-response bias? N  
If appropriate, was information about non-responders described? N  
Were the results internally consistent? Y  
Quality of Reporting 
Were the aims/objectives of the study clear? Y  
Was the target/reference population clearly defined? Y  
Is it clear what was used to determine statistical significance and/or 
precision estimates? 
Y  
Were the methods (including statistical methods) sufficiently 
described to enable them to be repeated? 
Y  
Were the basic data adequately described? Y  
Were the results presented for all the analysis described in the 
methods? 
Y  
Were the limitations of the study discussed? Y  
Covariates Age, Education, Depression 
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Zhong et al. (2017) 
 
 Yes/No/Don’t know (Y/N/DK) Comments 
Study Design Quality 
Was the study design appropriate for the stated aims? Y  
Was the sample size justified? N  
Was the sample frame taken from an appropriate population base so 
that it closely represented the target/reference population under 
investigation? 
Y  
Were the risk factor and outcome variables measured appropriate to 
the aims of the study? 
Y  
Were the authors’ discussions and conclusions justified by the 
results? 
Y  
Were there any funding sources or conflicts of interest that may 
affect the authors’ interpretation of the results? 
Y One author is also 
director of funding 
institution  
Was ethical approval or consent of participants attained? DK Not mentioned 
Risk of Biases 
Was the selection process likely to select subjects/participants that 
were representative of the target/reference population under 
investigation? 
Y  
Were measures undertaken to address and categorise non-
responders 
N  
Were the risk factor and outcome variables measured correctly using 
instruments/measurements that had been trialled, piloted or 
published previously? 
N  
Does the response rate raise concerns about non-response bias? Y Attrition at follow up 
If appropriate, was information about non-responders described? N  
Were the results internally consistent? Y  
Quality of Reporting 
Were the aims/objectives of the study clear? Y  
Was the target/reference population clearly defined? Y  
Is it clear what was used to determine statistical significance and/or 
precision estimates? 
Y  
Were the methods (including statistical methods) sufficiently 
described to enable them to be repeated? 
Y  
Were the basic data adequately described? Y  
Were the results presented for all the analysis described in the 
methods? 
Y  
Were the limitations of the study discussed? Y  
Covariates Number of Chronic Conditions, Age, Gender, Education, 
Socioeconomic status, Physical Exercise, Smoking, Social 
Activity, Social Isolation 
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Wilson et al. (2007) 
 
 Yes/No/Don’t know (Y/N/DK) Comments 
Study Design Quality 
Was the study design appropriate for the stated aims? Y  
Was the sample size justified? N  
Was the sample frame taken from an appropriate population base so 
that it closely represented the target/reference population under 
investigation? 
Y  
Were the risk factor and outcome variables measured appropriate to 
the aims of the study? 
Y  
Were the authors’ discussions and conclusions justified by the 
results? 
Y  
Were there any funding sources or conflicts of interest that may 
affect the authors’ interpretation of the results? 
N  
Was ethical approval or consent of participants attained? Y  
Risk of Biases 
Was the selection process likely to select subjects/participants that 
were representative of the target/reference population under 
investigation? 
Y  
Were measures undertaken to address and categorise non-
responders 
N  
Were the risk factor and outcome variables measured correctly using 
instruments/measurements that had been trialled, piloted or 
published previously? 
Y Modified verision of de 
Jong Gierveld 
Loneliness Scale –  
Cronbach coefficient a 
was .78, comparable to 
original scale 
Does the response rate raise concerns about non-response bias? N  
If appropriate, was information about non-responders described? N  
Were the results internally consistent? Y  
Quality of Reporting 
Were the aims/objectives of the study clear? Y  
Was the target/reference population clearly defined? Y  
Is it clear what was used to determine statistical significance and/or 
precision estimates? 
Y  
Were the methods (including statistical methods) sufficiently 
described to enable them to be repeated? 
Y  
Were the basic data adequately described? Y  
Were the results presented for all the analysis described in the 
methods? 
Y  
Were the limitations of the study discussed? Y  
Covariates Age, Sex, Education, Depressive Symptoms, Social 
Network Size, Social Activity Frequency, Cognitive 
Activity, Physical Activity, , Race/Ethinicity, Income level, 
Disability, Vascular Risk Factors and Conditions 
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Appendix 1.3. Psychometric tools used to assess loneliness  
 
Psychometric Tool, 
Author  
Description and 
Scoring 
Psychometric 
Properties 
Studies Utilising 
Measure within 
Systematic Review 
De-Jong Gierveld 
Scale for Loneliness 
(De Jong Gierveld & 
Van Tilburg, 2006) 
Six-item, Likert style 
questionnaire that 
includes three 
negatively worded 
items and three 
positively worded 
items. Negatively 
worded items are 
reverse scored and 
sum of the scores 
ranges from 0-24 with 
higher scores 
indicating greater 
levels of loneliness 
Cronbach’s µ ranging 
from 0.70-0.76 (De 
Jong Gierveld & Van 
Tilburg, 2006), 0.78 
(Wilson et al., 2007), 
and 0.79 (Tijhuis et 
al., 1999). 
Tijhuis et al. (1999) 
 
Wilson et al.. (2007) 
used a modified 
version of the scale 
University of 
California, Los 
Angeles (UCLA) 
Loneliness Scale 
(version 3) 
(Russell, 1996), 
20 items with a 4 
point Likert scale 
(ranging from ‘never’ 
to ‘often’) to assess 
how often individuals 
felt the way described 
in the loneliness items 
The measure has high 
internal consistency 
(coefficient alpha 
ranging from .89-.94 
(Russell, 1996), but it 
was not reported by 
Tzang et al. (2015) 
Tzang et al. (2015) 
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Abstract 
The efficacy and effectiveness of Cognitive Stimulation Therapy in improving cognition 
and quality of life (QoL) in individuals with dementia has been well demonstrated (e.g. 
Spector Thorgrimsen, Woods et al., 2003). However, less is known about the mechanisms 
of change for these outcomes. This study aims to pay attention to mechanisms of change 
for CST, such as social connectedness and self-efficacy. A within group repeated measure 
study will be adopted. Participants will include older adults with mild-moderate dementia 
participating in CST groups being carried out within Older People Community Mental 
Health Teams across Greater Glasgow and Clyde. A total of 47 participants will be asked 
to complete assessment measures relating to social connectedness and self-efficacy prior 
to, during, and following CST intervention. Dependant T-tests will be used to explore 
whether there is a significant difference in outcome scores pre-post intervention. A 
correlation analysis will be used to examine the relationship between improvements in 
cognition and QoL scores and improvements in social connectedness and self-efficacy 
scores. This research could be used to help better match patients to CST intervention, and 
help to develop further therapeutic approaches for use with patients with dementia. 
Introduction 
The age profile of Scotland’s population is changing rapidly and, as populations age, it is 
expected that the global burden of dementia will continue to escalate. Currently, there are 
around 800,000 people with dementia in the UK. By 2040, the number of people with the 
condition is expected to double (House of Commons Library, 2016). As such, the need for 
effective and accessible treatments for dementia is paramount. 
Cognitive Stimulation Therapy 
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Cognitive stimulation therapy (CST) is a brief, evidence-based, psychosocial group 
intervention, which aims to optimise cognitive function for persons with mild to moderate 
dementia. CST focuses on fostering individual strengths through themed sessions that 
incorporate therapeutic techniques such as reality orientation or reminiscence. Reality 
orientation is intended to facilitate memory through the presentation and repetition of 
information, that serves as factual reminders about the self or the environment (Douglas, 
James & Ballard, 2004). Reminiscence therapy involves discussion of past activities, 
events or experiences often using concrete prompts (Spector, Davies, Woods et al., 2000). 
Evidence shows CST enhances cognition and improves quality of life (QoL) of those with 
a dementia (Knapp, Thorgrimsen, Patel et al., 2006; Spector, Thorgrimsen, Woods et al., 
2003). It is currently the only nonpharmacological intervention recommended to improve 
cognition for those with mild to moderate dementia (Nice, 2007). Whilst studies have 
evidenced the efficacy and effectiveness of CST, less attention has been paid to 
mechanisms of change.  
 
Spector, Gardner & Orrell (2011) carried out a qualitative study of experiences of the 
people attending CST groups, carers and group facilitators. Themes from patients, carers 
and group facilitators indicate positive experience when commenting on the experience of 
patients in groups and changes in everyday life. In a recent RCT investigating 
individualised CST being delivered via patient family/carer dyads, results revealed this to 
be less effective, with no significant differences found for cognition or QoL (Orgeta, 
Leung, Kang et al., 2015). This suggests that the socially orientated group context of 
traditional CST may, in part, contribute to positive outcomes.  
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Social Connectedness 
 
Studies investigating social contexts and their association with mental health and well-
being among older adults (OA) have shown that greater social network integration is 
protective against mental ill health (e.g. Chan, Malhotra, Malhotra et al, 2011; Chao, 2011; 
Fiori, Antonucci, & Cortina, 2006). 
 
Older adults are particularly likely to experience age-related losses that affect their social 
relationships. Within those relationships that remain, individuals with dementia may have 
additional challenges making meaningful social connections due to increased difficulties 
with communication. Indeed, social connectedness has been shown to be affected during 
the early stages of dementia (Hatch, 2013).  
 
Self-Efficacy 
 
Self-efficacy refers to a person’s belief in his or her ability to succeed in a specific 
situation or accomplish a specific task (Bandura, 1977). Higher general self-efficacy has 
been related to better QoL in patients with acquired brain injury (ABI) (Brands, Kohler, 
Stapert et al., 2014) as well as chronic conditions, such as chronic obstructive pulmonary 
disease (COPD) (Bentsen, Wentzel-Larsen, Henriksen et al., 2010). Symptoms of dementia 
lead to significant disruptions in social and occupational participation (American 
Psychiatric Association, 2013) and patients experience a tremendous loss of control in their 
lives.  
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As mentioned above, CST focuses on fostering individual strengths and is carried out in a 
socially orientated context. As such, it may be that changes in QoL and cognition 
following participation in CST groups are related (in part) to an increase in social 
connectedness and self-efficacy.  
 
Aims and Hypothesis 
 
This study aims to investigate whether there are changes in social connectedness and self-
efficacy from pre-to post CST group, and whether changes in these variables are also 
related to changes in cognition and QoL.  
 
Method 
 
Design  
A within group repeated measures design will be adopted.  
 
Sample 
 
Participants will include community-dwelling people with a diagnosis of mild to moderate 
dementia. Participants will be recruited by convenience sampling from those attending 
CST groups within Older People Community Mental Health Teams (OPCMHTs) within 
Greater Glasgow and Clyde.  
 
Inclusion Criteria 
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Inclusion criteria will be as set out in the previous CST trial (Spector et al., 2003). This is 
also the current inclusion criteria for individuals attending clinical CST groups. These 
stipulated that participants (a) met the DSM-IV criteria for dementia (American Psychiatric 
Association, 1994), (b) scored between 10 and 24 on the Mini Mental State Examination 
(MMSE; Folstein, Folstein & McHugh, 1975), (c) had some ability to communicate and 
understand communication, (d) could see and hear well enough to participate in the group, 
(e) did not have a major physical illness or disability which compromised participation and 
(f) did not have a diagnosis of a learning disability. Both male and female participants will 
be included, aged 65 years and above.  
Cognitive screens will be carried out using the Mini-Addenbrooke’s Cognitive 
Examination (M-Ace; Hsieh, McGory, Leslie et al., 2014), as this is currently being 
routinely used within OPCMHTs due to a change in licensing laws for the MMSE. The M-
ACE is scored out of 30 with two cut-offs recommended: (1) 25/30 and (2) 21/30. First, 
the higher cut-off of 25/30 has both high sensitivity and specificity and is at least 5 times 
more likely to have come from a patient with dementia than without. A lower cut-off of 
21/30, by contrast, is almost certainly diagnostic of a dementia syndrome regardless of the 
prevalence rate.  
 
Rather than using cut off scores as part of inclusion criteria, these will be used as guides and adequate 
performance on mini-ACE will be judged by clinicians completing assessment.  
 
Exclusion Criteria 
People who lack the capacity to consent in research will be excluded.  
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Procedure 
 
Eligible individuals will be provided with information on the study by CST facilitators. 
Those expressing an interest to take part will be asked to consent to contact details being 
passed onto the researcher who will provide further information on the study. Written 
consent will be obtained before the study begins. Participants will then be invited to 
complete assessment measures prior to, during, and following CST intervention; 
administered by the researcher and CST facilitators. CST involves 14 structured 45 minute 
group therapy sessions, conducted twice weekly over a period of seven weeks, within 
participants’ local OPCMHT. Pre assessment measures will be administered prior to 
session three of CST groups, and post assessment measures within two weeks of CST 
groups completing. 
 
Outcome Measures 
There is an absence of validated measures for people with dementia regarding social 
connectedness and self-efficacy. However, Mak (2011) has argued that we should not 
assume that scales which are not designed for people with dementia cannot be completed 
meaningfully by people with mild to moderate dementia. Moreover, the scales that have 
been selected for the current study are simple and feedback from a small number of 
individuals participating in a current CST group in Inverclyde who volunteered to review 
the scales was that the measures were easy to understand and use, indicating they can be 
completed in a meaningful way by this client group.  
Social connectedness & Self-Efficacy 
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The primary outcome measures will include – a measure of ‘group fit’ (please see below). 
This measure has been used in previous research with older adults participating in a 
reminiscence group (Haslam, Haslam, Ysseldyk, et al., 2013), and will be used to assess 
participants’ perceived fit with their CST groups at the end of sessions one, seven, and 
fourteen. This scale takes very little time to complete.  
 
A second primary outcome measure will be – The Three Item Loneliness Scale (Hughes, 
Waite, Hawkley et al., 2004). This scale (please see below) will be administered pre and 
post CST intervention, it can be completed in under five minutes. 
 
A third primary outcome measure will be - The General Self-Efficacy scale (Shwarze & 
Jerusalem, 1995). This was created to assess a general sense of perceived self-efficacy with 
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the aim of predicting coping with daily hassles as well as adaptation after experiencing 
stressful life events. It has been used with older people with dementia (Sprange, Mountain, 
Shortland et al, 2015). This will be administered pre and post CST intervention and takes 
5-10 minutes to complete. 
Cognition and QoL 
 
Within Spector et al. (2003), significantly improved scores for the CST group were found 
on the following measures of cognition and QoL - the MMSE (p=0.044, 95% CI 0.57-2.27, 
d=0.37) the Alzheimer’s Disease Assessment scales- Cognition scales (ADAS-COG; 
Rosen, Mohs, Davis et al., 1984) (p=0.014, 95% CI 0.64-4.09, d=0.37) and the QoL-
Alzheimer’s Disease scale (QoL-AD; Logsdon, Gibbons, McCurry et al., 1999) (p=0.028, 
95% CI 0.09-3.18, d=0.39).  
 
Currently, OPCMHTs running CST groups routinely assess the efficacy and effectiveness 
of CST using the M-Ace and QoL-AD; the researcher will ask for participants’ consent to 
have access to these results. In addition, the researcher will administer the ADAS-COG pre 
and post CST intervention; this can take around 45 minutes to complete. These will be 
secondary outcome measures to help assess the efficacy and effectiveness of CST.  
Table 1: Procedure for administration of outcome measures 
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Health and Safety Issues 
 
Researcher 
 
Most assessment sessions will be conducted within OPCMHTs, which have procedures in 
place to minimise risk to staff that are adequate for this study. Home visits will be offered 
to participants who may find it difficult to attend their local OPCMHT for assessment 
sessions. All participants will be known to the OPCMHT and risk assessments will be 
carried out for participants by clinicians who have had recent contact with them. The 
researcher will adhere to the Greater Glasgow and Clyde lone worker policy during home 
visits.  
Participants 
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Assessment sessions will involve asking participants a range of questions which may cause 
distress. If this occurs, participants will be offered a break during the session and reminded 
their involvement in the study is voluntary and they can choose to discontinue at any time. 
Participants will also be given information on where they can seek further support should 
they wish (e.g. speak with their GP). The researcher will report any information given that 
highlights risk to the participant or another person to the clinical team.  
Having cognitive function assessed could also be stressful for some participants, and there 
is the risk that being assessed will uncover a problem with a participant’s cognitive 
function that they were not previously aware of. Making sure participants are fully 
informed and that pre-participation counselling is given should limit these risks to the 
participant. 
Sample Size 
There is no existing research literature regarding effect sizes for the primary outcome 
measures in similar studies. However, in their study, Spector et al. (2003) achieved small –
medium effect sizes on measures of cognition (d=0.37) and QoL (d=0.39). Using G Power 
(Faul et al., 2007) a sample size of 47 would be required to detect an effect size of 0.37 
using a within group t-test with a 0.05 (one-tailed) level of significance. As such, a sample 
size of 47 should have sufficient power to detect a change in outcome measure assessing 
QoL and cognition for the current study.  A sample size of 47 would have sufficient power 
(0.8) to detect a correlation of 0.35, with alpha at 0.05.  
Four OPCMHTs have provided data on the number of individuals typically completing 
CST in a 6 month period - this ranges from 68-100 depending upon uptake and drop out 
rates. This suggests a sample size of 47 is achievable in a six month period. 
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Data Handling 
All raw data will be kept in secure locked filing cabinet on NHS GG&C site that only the 
researcher will have access to. All data will be anonymised with a code linking to 
identifiable data. Anonymised data will be transferred onto a password protected 
University computer and kept for up to 12 months; thereafter, it will be transferred to the 
University’s Enlighten repository.  
Analysis 
A quantitative approach will be adopted. Descriptive statistics will be used to describe the 
demographic characteristics of the group. Dependant T-tests will be used to explore 
whether there is a significant difference in outcome scores pre-post intervention.  
 
A correlation analysis will then be adopted to determine if there is a relationship between 
improvement on cognition and QoL (using change scores for the M-ACE, ADAS-Cog, 
QOL-AD) and change in social connectedness and self-efficacy scores.  
 
Initial M-Ace scores will be used to determine if level of cognitive impairment moderates 
scores for the primary outcome measures.  
 
In their reminiscence study, Haslam et al (2013) found that initial perceived group fit 
scores predicted outcomes. As such, this study may also explore scores at time point one 
for social connectedness and self-efficacy to assess impact upon outcomes.  
 
Where data meets normal assumptions of distribution, parametric analysis methods will be 
used, otherwise non-parametric methods will be used.  
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Ethical Issues 
 
Regarding informed consent – the demands of making a decision to participate in the CST 
intervention overlap with the demands of making a decision to participate in research. 
Once clinicians within OPCMHTs have deemed individuals eligible for CST and 
individuals have consented to this intervention, clinicians will then also identify those 
whom they deem as having capacity to consent to research and invite them to take part in 
the current study. The researcher will then provide additional information regarding the 
study for those expressing an interest to take part. Those identified as having capacity to 
consent and wishing to take part in the study will be required to complete a written consent 
form.  
 
Those who lack the capacity to consent to research will be excluded. Ethical approval will 
be sought from the NHS West of Scotland research ethics committees.  
 
Financial Issues 
 
Anticipated costs will be photocopying costs for measures (£146.58) and travel expenses 
for the researcher (total expected to be no more than £200).  
 
Table 2: Proposed Timetable 
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Applications 
This study will contribute to the understanding of mechanisms for change with CST group 
interventions. This could help better match patients to CST intervention, and help to 
develop further therapeutic approaches for patients with dementia. 
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Proposal Appendix A. Plain English Summary 
 
An explorative study of the “active ingredients” that lead to positive outcomes following 
Cognitive Stimulation Therapy in dementia care 
Background 
Cognitive stimulation therapy (CST) is an evidence-based, psychosocial group 
intervention, which aims to optimise cognitive function for persons with mild to moderate 
dementia. Whilst CST has been shown to enhance cognitive function and quality of life 
(QoL) of those with a dementia (Spector, Thorgrimsen, Woods et al., 2003), less is known 
about the “active ingredients” of CST that lead to such positive outcomes.  
 
CST focuses on fostering individual strengths and is carried out in a social group 
environment. As such, it may be that changes in QoL and cognition following participation 
in CST groups are related (in part) to an increase in social connectedness and self-efficacy; 
these are discussed further below. 
 
Social Connectedness 
 
Several studies investigating social contexts and their association with mental health and 
well-being among older adults have shown that greater social network integration is 
protective against mental ill health (e.g. Chan et al., 2011). 
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Older adults are especially likely to experience age-related losses that affect their social 
relationships. Individuals with dementia may have additional challenges making 
meaningful social connections due to increased difficulties with communication.  
 
Self-Efficacy 
 
One’s sense of self-efficacy (a person’s belief in their ability to succeed in a specific 
situation) can play a major role in how one approaches goals, tasks, and situations. Those 
with dementia experience a decline in independence and a significant loss of control in 
their lives, likely impacting upon their self-efficacy.  
 
Aims 
 
This study aims to explore if social connectedness and self-efficacy improve for 
individuals following CST intervention. It also aims to investigate if improvements in 
social connectedness and self-efficacy are linked to positive outcomes found in cognition 
and QoL following participation in CST. 
Methods 
 
Participants will include older adults with a diagnosis of mild to moderate dementia who 
will be attending CST groups within Older People Community Mental Health Teams 
(OPCMHTs) across Greater Glasgow and Clyde. Participants will be provided with 
information on the study by CST group organisers, and will be required to sign a consent 
form to take part. Participants will be invited to complete assessment measures assessing 
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cognition, QoL, social connectedness and self-efficacy prior to, during, and following 
completion of the CST group.  
 
Applications 
 
This study will contribute to the understanding of the “active ingredients” that lead to 
positive outcomes found with CST interventions. This could help to better match patients 
to CST, and help develop further therapeutic approaches for patients with dementia. 
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Proposal Appendix B. Health and Safety form 
 
WEST OF SCOTLAND/ UNIVERSITY OF GLASGOW 
DOCTORATE IN CLINICAL PSYCHOLOGY 
HEALTH AND SAFETY FOR RESEARCHERS 
1. Title of Project An explorative study of the “active 
ingredients” that lead to positive 
outcomes following Cognitive 
Stimulation Therapy in dementia care. 
2. Trainee Ashley Gibson 
3. University Supervisor Professor Jon Evans 
4. Other Supervisor(s) Dr Stephanie Crawford 
5. Local Lead Clinician Dr Stephanie Crawford  
6. Participants:  (age,  group or sub-
group, pre- or post-treatment, etc) 
Participants will include community-dwelling 
older people (65 + years) with a diagnosis of 
mild to moderate dementia participating in CST 
groups. Participants will be recruited by 
convenience sampling from individuals 
identified as suitable to attend CST groups 
within Older People Community Mental Health 
Teams (OPCMHTs) across Greater Glasgow 
and Clyde. This will be a within repeated 
measures subjects design. 
7. Procedures to be applied  
(eg, questionnaire, interview, etc) 
 
Participants will be invited to complete 
psychometric assessment measures prior to, 
during, and following CST intervention; these 
will be administered by CST facilitators and the 
researcher. Pre and post measures will be 
administered within two weeks prior to and two 
weeks following CST.  
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Measures include: Mini-Addenbrooke’s 
Cognitive Examination (mini-Ace; Hsieh, 
McGory, Leslie et al., 2014), the Alzheimer’s 
Disease Assessment scales- Cognition scales 
(ADAS-COG; Rosen et al., 1984), the quality of 
life-Alzheimer’s Disease scale (QoL-AD; 
Logsdon et al., 1999), a ‘group fit’ measure to 
measure perceived social connectedness to CST 
group, The Three Item Loneliness Scale 
(Hughes, Waite, Hawkley et al., 2004) and The 
General Self-Efficacy scale (Shwarze & 
Jerusalem, 1995).  
8. Setting (where will procedures be 
carried out?) 
i) Details of all settings 
 
 
 
 
It is intended that most assessment sessions for 
this study will be conducted within OPCMHTs 
within Greater Glasgow and Clyde that 
participants will be attending as part of their 
CST group intervention. Home visits will be 
offered to participants who may find it difficult 
to attend their local OPCMHT for assessment 
sessions. 
 ii) Are home visits involved  Y (potentially) 
 
WEST OF SCOTLAND/ UNIVERSITY OF GLASGOW 
DOCTORATE IN CLINICAL PSYCHOLOGY 
 
HEALTH AND SAFETY FOR RESEARCHERS 
 
 
9. Potential Risk Factors Considered 
(for researcher and participant 
safety): 
i) Participants 
ii) Procedures 
iii) Settings 
Participants: The participants attending CST 
groups are a vulnerable client group with a 
diagnosis of mild to moderate dementia which 
raise issues regarding informed consent.  
Those participating in the study will have 
already been assessed as suitable (by assessing 
clinician within OPCMHT) for attending CST 
group. Those thought to have dangerous or 
unpredictable behavior, which may impact 
upon others within group (including attendees 
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and facilitators), would not be deemed suitable 
to attend CST and would therefore also be 
excluded from this study.  
Procedures: The assessment sessions will 
involve asking participants a range of 
questions which may cause distress. 
Settings: The majority of pre and post 
assessment sessions will likely be carried out 
within OPCMHTs that participants are already 
attending for CST intervention. However, 
home visits will be offered to those participants 
unable to attend their local OPCMHT for pre 
and post assessment sessions. This does raise 
potential risk for the researcher – this will be 
addressed below. There is also the issue if 
participants becoming distressed either in 
OPCMHT or at home during assessment 
sessions – this is also addressed below in 
section 10. 
10. . 10. Actions to minimise 
risk (refer to 9)  
i) Participants 
ii) Procedures 
iii) Settings 
 
 
 
 
 
 
Participants: Those who lack the capacity to 
consent to research will be excluded from the 
study. 
 
Participants will be known to their local 
OPCMHT and will initially be assessed by 
clinician from OPCMHT as being suitable for 
attending CST group and those deemed as 
having dangerous or unpredictable behavior 
would be excluded from CST - and 
consequently this study. When completing 
assessment sessions with participants, GG&C 
OPMHTs have procedures in place to 
minimise risk to staff and these are thought to 
be adequate for the proposed study for the 
researcher.  
Procedures: If the procedures of the current 
study result in any distress for participants, 
they will be offered a break during the session 
and reminded their involvement in the study is 
voluntary and they can choose to discontinue at 
any time. Participants will also be given 
information on where they can seek further 
support should they wish (e.g. speak with their 
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GP). The researcher will report any 
information given that highlights risk to the 
participant or another person to the clinical 
team. 
Settings: GG&C OPMHTs have procedures in 
place to minimise risk to staff and these are 
thought to be adequate for the proposed study 
for the researcher. Also, all participants will be 
known to the OPCMHT and as such risk 
assessments will be carried out by the clinical 
team prior to the researcher becoming involved 
with participants.   
If home visits are required, a risk assessment 
will be completed by a member of the clinical 
team who has had recent contact with the 
participant(s) and the researcher will 
familiarise themselves with any risk 
assessments. Any risks will be discussed with a 
member of the clinical team. The researcher 
will adhere to the Greater Glasgow and Clyde 
lone worker policy during any home visits and 
these will be conducted within working hours. 
If any immediate concerns arise during any 
home visits the researcher can contact a 
member of the clinical team over the 
telephone. 
 
 
 
 
Trainee signature:  ...........................................................Date:  .................................... 
 
University supervisor signature: .................................................. Date: ........................... 
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Proposal Appendix C. Equipment and Expenses Form 
 
RESEARCH EQUIPMENT, CONSUMABLES AND EXPENSES  
 
Trainee ……Ashley Gibson………………………………………………………………………       
 
Year of Course ……2………………………….    Intake Year…2015……………….. 
 
Please refer to latest stationary costs list (available from student support team) 
 
 
Item 
 
Details and Amount 
Required 
 
Cost or Specify if to Request 
to Borrow from Department 
 
Stationary 
 
 
Envelopes (A5) X 1 box 
(£8.52) 
 
Labels x 1 box (£3.17) 
 
 
 
 
 
Subtotal: £11.69 
 
Postage 
 
 
Free post costs x 47 (£29.14) Subtotal: £29.14 
 
Photocopying and Laser 
Printing   
Print black and white copies at 
5p each sheet 
 
Participant invite sheet (1 
page) x 47 (£2.35) 
 
Participant information sheet 
(4 page) x 47 copies (£9.40) 
 
Participant Consent form (1 
page) x 94 copies (£4.70) 
 
Perceived ‘group fit’ scale  
(1 page) x141 copies (£7.05) 
 
QoL Alzheimer’s disease scale 
(1 page) x 94 copies (£4.70) 
 
The Three Item Loneliness 
Scale (1 page) x94 copies 
(£4.70) 
 
Generalised Self Efficacy 
scale (1 page) x 94 (£4.70) 
 
Mini-Addenbrooke’s 
Cognitive Examination (2 
pages) x 94 copies (£9.40) 
 
Alzheimer’s Disease 
Assessment Scale – Cognition 
(12 pages) x 94 (£56.40) 
 
 
 
 
 
Subtotal: £105.75 
 
Equipment and Software 
N/A  
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Subtotal: 
 
Measures 
 
 
Only photocopying costs 
required as measures freely 
accessible (see above) 
 
 
 
Subtotal:  
 
Miscellaneous 
 
 
  
 
 
Subtotal: 
Total  £146.58 
 
For any request over £200 please provide further justification for all items that contribute to a high 
total cost estimate. Please also provide justification if costing for an honorarium: 
 
 
 
 
 
 
 
 
Trainee Signature…………………………………… …   Date……………………… 
 
Supervisor’s Signature ………………………………..    Date ……………………… 
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Appendix 2.4. Group Fit Measure 
 
 
 
